Advanced Search (OLGA)

Gene: SLCO2A1 (solute carrier organic anion transporter family member 2A1) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

SLCO2A1

Name:

solute carrier organic anion transporter family member 2A1

RGD ID:

736966

HGNC Page

HGNC:10955

Description:

Predicted to enable prostaglandin transmembrane transporter activity and sodium-independent organic anion transmembrane transporter activity. Predicted to be involved in prostaglandin transport and sodium-independent organic anion transport. Located in basal plasma membrane. Implicated in primary hypertrophic osteoarthropathy.

Type:

protein-coding

RefSeq Status:

REVIEWED

Previously known as:

MATR1; matrin F/G 1; OATP2A1; PGT; PHOAD; PHOAR2; prostaglandin transporter; SLC21A2; solute carrier family 21 (prostaglandin transporter), member 2; solute carrier family 21 member 2; solute carrier organic anion transporter family, member 2A1

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	3	133,932,701 - 134,029,925 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	3	133,932,701 - 134,052,184 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	3	133,651,545 - 133,748,769 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	3	135,134,230 - 135,231,418 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	3	135,134,239 - 135,231,426	NCBI
Celera	3	132,077,395 - 132,174,290 (-)	NCBI		Celera
Cytogenetic Map	3	q22.1-q22.2	NCBI
HuRef	3	131,029,670 - 131,126,922 (-)	NCBI		HuRef
CHM1_1	3	133,615,353 - 133,712,732 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	3	136,677,860 - 136,775,063 (-)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2A1	Human	genetic disease		IAGP	RGD:151762372\|RGD:151824224\|RGD:151840280\|RGD:152135742\|RGD:156111164\|RGD:156208468\|RGD:156230537\|RGD:156296263\|RGD:156442143\|RGD:401737209	8554872	ClinVar Annotator: match by term: Inborn genetic diseases	ClinVar	PMID:28492532
SLCO2A1	Human	genetic disease		IAGP	RGD:155979296\|RGD:155980170\|RGD:155996673\|RGD:155999207\|RGD:156252945\|RGD:156256007\|RGD:156265600\|RGD:329382678\|RGD:401730109\|RGD:405772039\|RGD:405772046\|RGD:405772052\|RGD:405772058\|RGD:405772065\|RGD:407452144\|RGD:407452146\|RGD:407493546\|RGD:407493551\|RGD:407493555\|RGD:407493559\|RGD:597627521\|RGD:597627524\|RGD:597627527\|RGD:597627530\|RGD:597627534\|RGD:597627537\|RGD:597627538	8554872	ClinVar Annotator: match by term: Inborn genetic diseases	ClinVar
SLCO2A1	Human	primary hypertrophic osteoarthropathy		IAGP	RGD:15189676	8554872	ClinVar Annotator: match by term: PACHYDERMOPERIOSTOSIS, AUTOSOMAL RECESSIVE	ClinVar	PMID:25741868\|PMID:28492532
SLCO2A1	Human	primary hypertrophic osteoarthropathy		IAGP	RGD:405656569	8554872	ClinVar Annotator: match by term: Pachydermoperiostosis syndrome	ClinVar	PMID:20083684\|PMID:22197487\|PMID:22331663\|PMID:23509104\|PMID:25741868
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Dominant		IAGP	RGD:15136542\|RGD:15166276\|RGD:151710872\|RGD:15181754\|RGD:15183645\|RGD:15203365\|RGD:152040838\|RGD:401737209	8554872	ClinVar Annotator: match by term: SLCO2A1-related condition	ClinVar	PMID:28492532
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Dominant		IAGP	RGD:12907303	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal dominant	ClinVar	PMID:24153155\|PMID:24929850\|PMID:25741868\|PMID:26539716\|PMID:27134495\|PMID:28425581\|PMID:28492532\|PMID:29313109\|PMID:33852188
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Dominant		IAGP	RGD:127287836	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal dominant	ClinVar	PMID:23509104\|PMID:28425581
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Dominant		IAGP	RGD:13435624	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal dominant	ClinVar	PMID:22197487\|PMID:22553128\|PMID:23509104\|PMID:26539716\|PMID:28425581\|PMID:28492532\|PMID:33852188
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Dominant		IAGP	RGD:150334989\|RGD:15103864\|RGD:15189676	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal dominant \| ClinVar Annotator: match by more ...	ClinVar	PMID:25741868\|PMID:28492532
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Dominant		IAGP	RGD:127287845	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal dominant	ClinVar	PMID:28425581\|PMID:28492532\|PMID:33852188
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Dominant		IAGP	RGD:8603136	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal dominant	ClinVar	PMID:16283874\|PMID:22553128\|PMID:22906430\|PMID:23509104\|PMID:24838973\|PMID:28492532
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Dominant		IAGP	RGD:150481941	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal dominant	ClinVar	PMID:25741868
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Dominant		IAGP	RGD:127287839	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal dominant	ClinVar	PMID:27134495
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 1		IAGP	RGD:15189676	8554872	ClinVar Annotator: match by term: PDP, AUTOSOMAL RECESSIVE	ClinVar	PMID:25741868\|PMID:28492532
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:127287843	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:33852188
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:8568172	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:22197487\|PMID:22553128\|PMID:23509104\|PMID:28492532
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:151792641	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:25741868\|PMID:28425581\|PMID:28492532\|PMID:28963081\|PMID:37334733
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:150481941\|RGD:151727972\|RGD:151728384\|RGD:38462144\|RGD:401948260\|RGD:401948272\|RGD:596938352	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:25741868
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:8602153	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:22197487\|PMID:22696055\|PMID:28425581\|PMID:28492532\|PMID:29264471\|PMID:33852188
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:402487676\|RGD:402487681\|RGD:402487687\|RGD:402487699	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:28425581
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:329848349\|RGD:401726225\|RGD:402487692	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:25741868\|PMID:28425581
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:150334989\|RGD:15154909\|RGD:151829232\|RGD:15189676	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 \| ClinVar Annotator: match more ...	ClinVar	PMID:25741868\|PMID:28492532
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:151740128	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:28425581\|PMID:28492532\|PMID:30931527
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:151874775	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:23509104\|PMID:28425581\|PMID:28492532\|PMID:28963081\|PMID:30154299
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:8603133	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:22331663\|PMID:28425581
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:150338345\|RGD:150338346\|RGD:150338347\|RGD:25314789\|RGD:25314797\|RGD:39456789\|RGD:39456850\|RGD:39456851\|RGD:401915499	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:402487704\|RGD:402487711	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:22696055
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:127287836	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:23509104\|PMID:28425581
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:155937379	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:24153155\|PMID:24929850\|PMID:28492532\|PMID:37915296
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:402487666\|RGD:402487727	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:26539716
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:12907303	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:24153155\|PMID:24929850\|PMID:25741868\|PMID:26539716\|PMID:27134495\|PMID:28425581\|PMID:28492532\|PMID:29313109\|PMID:33852188
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:402487719	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:23509104
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:402487954	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:26539716\|PMID:28425581
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:12907355	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:22197487\|PMID:22696055\|PMID:22906430\|PMID:24012041\|PMID:24153155\|PMID:24929850\|PMID:25741868\|PMID:25810087\|PMID:26072672\|PMID:26539716\|PMID:27134495\|PMID:28492532\|PMID:29313109
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:13435624	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:22197487\|PMID:22553128\|PMID:23509104\|PMID:26539716\|PMID:28425581\|PMID:28492532\|PMID:33852188
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:127287843\|RGD:127287847	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:33852188
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:39456852	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:24153155\|PMID:25741868\|PMID:26539716\|PMID:28425581\|PMID:28492532\|PMID:28963081\|PMID:29313109\|PMID:37915296
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:127287845	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:28425581\|PMID:28492532\|PMID:33852188
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:8603136	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:16283874\|PMID:22553128\|PMID:22906430\|PMID:23509104\|PMID:24838973\|PMID:28492532
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:8603134	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:22553128\|PMID:25741868\|PMID:28492532
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:15189676	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:28492532
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:8569945	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:22331663
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:8568171	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:22197487
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:8603135	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:22553128
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP	RGD:12907425	8554872	ClinVar Annotator: match by term: Hypertrophic osteoarthropathy, primary, autosomal recessive, 2	ClinVar	PMID:22906430\|PMID:24929850\|PMID:25741868
SLCO2A1	Human	Primary Lymphedema with Myelodysplasia		IAGP	RGD:150337922	8554872	ClinVar Annotator: match by term: Emberger syndrome	ClinVar	PMID:22147895\|PMID:25741868

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2A1	Human	autism spectrum disorder		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD	PMID:35663546
SLCO2A1	Human	basal cell carcinoma		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD	PMID:36428691
SLCO2A1	Human	Colorectal Neoplasms		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD	PMID:30510241
SLCO2A1	Human	Drug-Related Side Effects and Adverse Reactions		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD	PMID:15805072
SLCO2A1	Human	primary hypertrophic osteoarthropathy		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Dominant		IAGP		7240710		OMIM
SLCO2A1	Human	Primary Hypertrophic Osteoarthropathy, Autosomal Recessive, 2		IAGP		7240710		OMIM

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2A1	Human	(+)-schisandrin B	multiple interactions	ISO	RGD:3051	6480464	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLCO2A1 mRNA]	CTD	PMID:31150632
SLCO2A1	Human	(S)-nicotine	increases expression	EXP		6480464	Nicotine results in increased expression of SLCO2A1 mRNA	CTD	PMID:23825647
SLCO2A1	Human	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	EXP		6480464	o,p'-DDT results in increased expression of SLCO2A1 mRNA	CTD	PMID:19371625
SLCO2A1	Human	1,2-dimethylhydrazine	decreases expression	ISO	RGD:736967	6480464	1,2-Dimethylhydrazine results in decreased expression of SLCO2A1 mRNA	CTD	PMID:22206623
SLCO2A1	Human	17beta-estradiol	multiple interactions	EXP		6480464	[Estradiol binds to ESR2 protein] which results in increased expression of SLCO2A1 mRNA; [Estradiol co-treated more ...	CTD	PMID:20404318\|PMID:20660070\|PMID:30165855
SLCO2A1	Human	17beta-estradiol	increases expression	ISO	RGD:736967	6480464	Estradiol results in increased expression of SLCO2A1 mRNA	CTD	PMID:39298647
SLCO2A1	Human	17beta-estradiol	increases expression	EXP		6480464	Estradiol results in increased expression of SLCO2A1 mRNA	CTD	PMID:23019147
SLCO2A1	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		6480464	Tetrachlorodibenzodioxin results in increased expression of SLCO2A1 mRNA	CTD	PMID:20106945
SLCO2A1	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:3051	6480464	Tetrachlorodibenzodioxin results in increased expression of SLCO2A1 mRNA	CTD	PMID:34747641
SLCO2A1	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:3051	6480464	Tetrachlorodibenzodioxin results in decreased expression of SLCO2A1 mRNA	CTD	PMID:20959002\|PMID:21215274
SLCO2A1	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:736967	6480464	Tetrachlorodibenzodioxin affects the expression of SLCO2A1 mRNA	CTD	PMID:21570461
SLCO2A1	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:736967	6480464	Tetrachlorodibenzodioxin results in decreased expression of SLCO2A1 mRNA	CTD	PMID:19770486
SLCO2A1	Human	2,4-dinitrotoluene	affects expression	ISO	RGD:3051	6480464	2,4-dinitrotoluene affects the expression of SLCO2A1 mRNA	CTD	PMID:21346803
SLCO2A1	Human	2-methoxyethanol	increases expression	ISO	RGD:3051	6480464	methyl cellosolve results in increased expression of SLCO2A1 mRNA	CTD	PMID:21061450
SLCO2A1	Human	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:3051	6480464	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of SLCO2A1 mRNA	CTD	PMID:20959002
SLCO2A1	Human	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:736967	6480464	bisphenol S results in increased expression of SLCO2A1 mRNA	CTD	PMID:30951980
SLCO2A1	Human	4,4'-sulfonyldiphenol	increases expression	EXP		6480464	bisphenol S results in increased expression of SLCO2A1 mRNA	CTD	PMID:34831106
SLCO2A1	Human	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:736967	6480464	[bisphenol S co-treated with Tretinoin] results in decreased expression of SLCO2A1 mRNA	CTD	PMID:30951980
SLCO2A1	Human	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:736967	6480464	Fenretinide results in increased expression of SLCO2A1 mRNA	CTD	PMID:28973697
SLCO2A1	Human	5-aza-2'-deoxycytidine	multiple interactions	EXP		6480464	Rifampin inhibits the reaction [Decitabine results in increased expression of SLCO2A1 mRNA]	CTD	PMID:23137910
SLCO2A1	Human	5-aza-2'-deoxycytidine	increases expression	EXP		6480464	Decitabine results in increased expression of SLCO2A1 mRNA	CTD	PMID:23137910
SLCO2A1	Human	5-fluorouracil	affects expression	EXP		6480464	Fluorouracil affects the expression of SLCO2A1 mRNA	CTD	PMID:16584549
SLCO2A1	Human	acetamide	decreases expression	ISO	RGD:3051	6480464	acetamide results in decreased expression of SLCO2A1 mRNA	CTD	PMID:31881176
SLCO2A1	Human	aflatoxin B1	decreases expression	ISO	RGD:736967	6480464	Aflatoxin B1 results in decreased expression of SLCO2A1 mRNA	CTD	PMID:19770486
SLCO2A1	Human	aflatoxin B1	increases expression	EXP		6480464	Aflatoxin B1 results in increased expression of SLCO2A1 mRNA	CTD	PMID:32234424
SLCO2A1	Human	aflatoxin B1	decreases methylation	EXP		6480464	Aflatoxin B1 results in decreased methylation of SLCO2A1 intron	CTD	PMID:30157460
SLCO2A1	Human	aflatoxin B1	increases methylation	EXP		6480464	Aflatoxin B1 results in increased methylation of SLCO2A1 gene	CTD	PMID:27153756
SLCO2A1	Human	all-trans-retinoic acid	increases expression	EXP		6480464	Tretinoin results in increased expression of SLCO2A1 mRNA	CTD	PMID:21934132
SLCO2A1	Human	all-trans-retinoic acid	multiple interactions	ISO	RGD:736967	6480464	[bisphenol A co-treated with Tretinoin] results in decreased expression of SLCO2A1 mRNA; [bisphenol F co-treated more ...	CTD	PMID:30951980
SLCO2A1	Human	antirheumatic drug	decreases expression	EXP		6480464	Antirheumatic Agents results in decreased expression of SLCO2A1 mRNA	CTD	PMID:24449571
SLCO2A1	Human	aristolochic acid A	decreases expression	EXP		6480464	aristolochic acid I results in decreased expression of SLCO2A1 mRNA	CTD	PMID:33212167
SLCO2A1	Human	arsane	decreases expression	ISO	RGD:736967	6480464	Arsenic results in decreased expression of SLCO2A1 mRNA	CTD	PMID:19654921
SLCO2A1	Human	arsane	decreases expression	EXP		6480464	Arsenic results in decreased expression of SLCO2A1 mRNA	CTD	PMID:36861143
SLCO2A1	Human	arsane	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
SLCO2A1	Human	arsenic atom	decreases expression	ISO	RGD:736967	6480464	Arsenic results in decreased expression of SLCO2A1 mRNA	CTD	PMID:19654921
SLCO2A1	Human	arsenic atom	decreases expression	EXP		6480464	Arsenic results in decreased expression of SLCO2A1 mRNA	CTD	PMID:36861143
SLCO2A1	Human	arsenic atom	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
SLCO2A1	Human	atrazine	affects methylation	ISO	RGD:3051	6480464	Atrazine affects the methylation of SLCO2A1 gene	CTD	PMID:35440735
SLCO2A1	Human	Benoxacor	decreases expression	ISO	RGD:736967	6480464	benoxacor results in decreased expression of SLCO2A1 mRNA	CTD	PMID:34850242
SLCO2A1	Human	benzo[a]pyrene	increases expression	EXP		6480464	Benzo(a)pyrene results in increased expression of SLCO2A1 mRNA	CTD	PMID:20106945\|PMID:32234424
SLCO2A1	Human	benzo[a]pyrene	affects methylation	EXP		6480464	Benzo(a)pyrene affects the methylation of SLCO2A1 intron	CTD	PMID:30157460
SLCO2A1	Human	benzo[a]pyrene	affects expression	ISO	RGD:736967	6480464	Benzo(a)pyrene affects the expression of SLCO2A1 mRNA	CTD	PMID:22342234
SLCO2A1	Human	benzo[a]pyrene	increases expression	ISO	RGD:736967	6480464	Benzo(a)pyrene results in increased expression of SLCO2A1 mRNA	CTD	PMID:22228805
SLCO2A1	Human	benzo[a]pyrene	decreases expression	ISO	RGD:736967	6480464	Benzo(a)pyrene results in decreased expression of SLCO2A1 mRNA	CTD	PMID:19770486
SLCO2A1	Human	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:736967	6480464	Diethylhexyl Phthalate results in decreased expression of SLCO2A1 mRNA	CTD	PMID:15919853
SLCO2A1	Human	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:736967	6480464	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated more ...	CTD	PMID:33316053
SLCO2A1	Human	bis(2-ethylhexyl) phthalate	increases expression	EXP		6480464	Diethylhexyl Phthalate results in increased expression of SLCO2A1 mRNA	CTD	PMID:31163220
SLCO2A1	Human	bisphenol A	increases expression	EXP		6480464	bisphenol A results in increased expression of SLCO2A1 mRNA	CTD	PMID:19371625\|PMID:23019147\|PMID:34831106
SLCO2A1	Human	bisphenol A	increases expression	ISO	RGD:736967	6480464	bisphenol A results in increased expression of SLCO2A1 mRNA	CTD	PMID:32156529\|PMID:34585602
SLCO2A1	Human	bisphenol A	decreases expression	ISO	RGD:3051	6480464	bisphenol A results in decreased expression of SLCO2A1 mRNA	CTD	PMID:32145629\|PMID:34947998
SLCO2A1	Human	bisphenol A	decreases expression	ISO	RGD:736967	6480464	bisphenol A results in decreased expression of SLCO2A1 mRNA	CTD	PMID:30951980
SLCO2A1	Human	bisphenol A	multiple interactions	ISO	RGD:736967	6480464	[bisphenol A co-treated with Tretinoin] results in decreased expression of SLCO2A1 mRNA	CTD	PMID:30951980
SLCO2A1	Human	bisphenol A	increases methylation	ISO	RGD:736967	6480464	bisphenol A results in increased methylation of SLCO2A1 promoter	CTD	PMID:27312807
SLCO2A1	Human	bisphenol A	affects expression	ISO	RGD:3051	6480464	bisphenol A affects the expression of SLCO2A1 mRNA	CTD	PMID:25181051
SLCO2A1	Human	bisphenol F	multiple interactions	ISO	RGD:736967	6480464	[bisphenol F co-treated with Tretinoin] results in decreased expression of SLCO2A1 mRNA	CTD	PMID:30951980
SLCO2A1	Human	bisphenol F	increases expression	EXP		6480464	bisphenol F results in increased expression of SLCO2A1 mRNA	CTD	PMID:34831106
SLCO2A1	Human	bisphenol F	increases expression	ISO	RGD:736967	6480464	bisphenol F results in increased expression of SLCO2A1 mRNA	CTD	PMID:30951980\|PMID:38685157
SLCO2A1	Human	bleomycin A2	increases response to substance	ISO	RGD:736967	6480464	SLCO2A1 gene mutant form results in increased susceptibility to Bleomycin	CTD	PMID:32828905
SLCO2A1	Human	bleomycin A2	multiple interactions	ISO	RGD:736967	6480464	[SLCO2A1 gene mutant form results in increased susceptibility to Bleomycin] which results in increased expression more ...	CTD	PMID:32828905
SLCO2A1	Human	Butylbenzyl phthalate	multiple interactions	ISO	RGD:736967	6480464	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated more ...	CTD	PMID:33316053
SLCO2A1	Human	C60 fullerene	increases expression	ISO	RGD:3051	6480464	fullerene C60 results in increased expression of SLCO2A1 mRNA	CTD	PMID:19167457
SLCO2A1	Human	chlordecone	increases expression	ISO	RGD:736967	6480464	Chlordecone results in increased expression of SLCO2A1 mRNA	CTD	PMID:33711761
SLCO2A1	Human	chlordecone	affects expression	ISO	RGD:736967	6480464	Chlordecone affects the expression of SLCO2A1 mRNA	CTD	PMID:29980752
SLCO2A1	Human	chloroprene	increases expression	ISO	RGD:736967	6480464	Chloroprene results in increased expression of SLCO2A1 mRNA	CTD	PMID:23125180
SLCO2A1	Human	choline	multiple interactions	ISO	RGD:3051	6480464	[Choline deficiency co-treated with Methionine deficiency] results in decreased expression of SLCO2A1 mRNA	CTD	PMID:38663832
SLCO2A1	Human	chromium(6+)	affects expression	ISO	RGD:736967	6480464	chromium hexavalent ion affects the expression of SLCO2A1 mRNA	CTD	PMID:28472532
SLCO2A1	Human	ciprofibrate	decreases expression	ISO	RGD:736967	6480464	ciprofibrate results in decreased expression of SLCO2A1 mRNA	CTD	PMID:15919853
SLCO2A1	Human	clofibrate	decreases expression	ISO	RGD:736967	6480464	Clofibrate results in decreased expression of SLCO2A1 mRNA	CTD	PMID:15919853
SLCO2A1	Human	copper(II) chloride	decreases expression	EXP		6480464	cupric chloride results in decreased expression of SLCO2A1 mRNA	CTD	PMID:38568856
SLCO2A1	Human	cyclosporin A	decreases expression	EXP		6480464	Cyclosporine results in decreased expression of SLCO2A1 mRNA	CTD	PMID:24907557
SLCO2A1	Human	dexamethasone	decreases expression	ISO	RGD:736967	6480464	Dexamethasone results in decreased expression of SLCO2A1 mRNA	CTD	PMID:15919853
SLCO2A1	Human	diazinon	increases methylation	EXP		6480464	Diazinon results in increased methylation of SLCO2A1 gene	CTD	PMID:22964155
SLCO2A1	Human	dibutyl phthalate	increases expression	ISO	RGD:736967	6480464	Dibutyl Phthalate results in increased expression of SLCO2A1 mRNA	CTD	PMID:21266533
SLCO2A1	Human	dibutyl phthalate	multiple interactions	ISO	RGD:736967	6480464	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated more ...	CTD	PMID:33316053
SLCO2A1	Human	dichloroacetic acid	decreases expression	ISO	RGD:736967	6480464	Dichloroacetic Acid results in decreased expression of SLCO2A1 mRNA	CTD	PMID:28962523\|PMID:34850242
SLCO2A1	Human	diclofenac	multiple interactions	EXP		6480464	Diclofenac inhibits the reaction [SLCO2A1 protein results in increased transport of Dinoprostone]	CTD	PMID:19843975
SLCO2A1	Human	diethyl maleate	decreases expression	ISO	RGD:3051	6480464	diethyl maleate results in decreased expression of SLCO2A1 mRNA	CTD	PMID:21161181
SLCO2A1	Human	diethyl phthalate	multiple interactions	ISO	RGD:736967	6480464	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated more ...	CTD	PMID:33316053
SLCO2A1	Human	diisobutyl phthalate	multiple interactions	ISO	RGD:736967	6480464	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated more ...	CTD	PMID:33316053
SLCO2A1	Human	diisononyl phthalate	multiple interactions	ISO	RGD:736967	6480464	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated more ...	CTD	PMID:33316053
SLCO2A1	Human	endosulfan	decreases expression	ISO	RGD:3051	6480464	Endosulfan results in decreased expression of SLCO2A1 mRNA	CTD	PMID:29391264
SLCO2A1	Human	esketamine	decreases expression	EXP		6480464	Esketamine results in decreased expression of SLCO2A1 mRNA	CTD	PMID:38219984
SLCO2A1	Human	ethylparaben	increases expression	EXP		6480464	ethyl-p-hydroxybenzoate results in increased expression of SLCO2A1 mRNA	CTD	PMID:37690743
SLCO2A1	Human	ferric oxide	increases expression	ISO	RGD:3051	6480464	ferric oxide analog results in increased expression of SLCO2A1 mRNA	CTD	PMID:38615722
SLCO2A1	Human	flutamide	decreases expression	ISO	RGD:3051	6480464	Flutamide results in decreased expression of SLCO2A1 mRNA	CTD	PMID:24136188
SLCO2A1	Human	furan	decreases expression	ISO	RGD:3051	6480464	furan results in decreased expression of SLCO2A1 mRNA	CTD	PMID:25539665
SLCO2A1	Human	genistein	increases expression	EXP		6480464	Genistein results in increased expression of SLCO2A1 mRNA	CTD	PMID:19371625\|PMID:23019147
SLCO2A1	Human	genistein	increases expression	ISO	RGD:736967	6480464	Genistein results in increased expression of SLCO2A1 mRNA	CTD	PMID:32186404
SLCO2A1	Human	indometacin	multiple interactions	EXP		6480464	Indomethacin promotes the reaction [SLCO2A1 protein results in increased transport of Dinoprostone]	CTD	PMID:19843975
SLCO2A1	Human	ketoprofen	multiple interactions	EXP		6480464	Ketoprofen promotes the reaction [SLCO2A1 protein results in increased transport of Dinoprostone]	CTD	PMID:19843975
SLCO2A1	Human	L-methionine	multiple interactions	ISO	RGD:3051	6480464	[Choline deficiency co-treated with Methionine deficiency] results in decreased expression of SLCO2A1 mRNA	CTD	PMID:38663832
SLCO2A1	Human	lead diacetate	increases expression	ISO	RGD:3051	6480464	lead acetate results in increased expression of SLCO2A1 mRNA	CTD	PMID:22641619
SLCO2A1	Human	lead diacetate	decreases expression	EXP		6480464	lead acetate results in decreased expression of SLCO2A1 mRNA	CTD	PMID:38568856
SLCO2A1	Human	lumiracoxib	multiple interactions	EXP		6480464	lumiracoxib inhibits the reaction [SLCO2A1 protein results in increased transport of Dinoprostone]	CTD	PMID:19843975
SLCO2A1	Human	manganese atom	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
SLCO2A1	Human	manganese(0)	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
SLCO2A1	Human	manganese(II) chloride	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
SLCO2A1	Human	methotrexate	decreases expression	EXP		6480464	Methotrexate results in decreased expression of SLCO2A1 mRNA	CTD	PMID:17400583
SLCO2A1	Human	methoxychlor	affects methylation	ISO	RGD:3051	6480464	Methoxychlor affects the methylation of SLCO2A1 gene	CTD	PMID:35440735
SLCO2A1	Human	methylmercury chloride	increases expression	ISO	RGD:3051	6480464	methylmercuric chloride results in increased expression of SLCO2A1 mRNA	CTD	PMID:31378766
SLCO2A1	Human	mifepristone	multiple interactions	EXP		6480464	Mifepristone promotes the reaction [Progesterone affects the expression of SLCO2A1 mRNA]	CTD	PMID:22414680
SLCO2A1	Human	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:3051	6480464	[Permethrin co-treated with DEET] results in decreased methylation of SLCO2A1 gene	CTD	PMID:33148267
SLCO2A1	Human	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:736967	6480464	Ethylnitrosourea results in increased mutagenesis of SLCO2A1 mRNA	CTD	PMID:27776689
SLCO2A1	Human	N-nitrosodiethylamine	increases expression	ISO	RGD:3051	6480464	Diethylnitrosamine results in increased expression of SLCO2A1 mRNA	CTD	PMID:20360939
SLCO2A1	Human	N-nitrosodiethylamine	multiple interactions	ISO	RGD:736967	6480464	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of SLCO2A1 mRNA	CTD	PMID:24535843
SLCO2A1	Human	naproxen	multiple interactions	EXP		6480464	Naproxen promotes the reaction [SLCO2A1 protein results in increased transport of Dinoprostone]	CTD	PMID:19843975
SLCO2A1	Human	nefazodone	decreases expression	ISO	RGD:3051	6480464	nefazodone results in decreased expression of SLCO2A1 mRNA	CTD	PMID:24136188
SLCO2A1	Human	nicotine	increases expression	EXP		6480464	Nicotine results in increased expression of SLCO2A1 mRNA	CTD	PMID:23825647
SLCO2A1	Human	nimesulide	decreases expression	ISO	RGD:3051	6480464	nimesulide results in decreased expression of SLCO2A1 mRNA	CTD	PMID:24136188
SLCO2A1	Human	okadaic acid	increases expression	EXP		6480464	Okadaic Acid results in increased expression of SLCO2A1 mRNA	CTD	PMID:38832940
SLCO2A1	Human	ozone	decreases expression	ISO	RGD:3051	6480464	Ozone results in decreased expression of SLCO2A1 mRNA	CTD	PMID:16716893
SLCO2A1	Human	paracetamol	affects expression	ISO	RGD:736967	6480464	Acetaminophen affects the expression of SLCO2A1 mRNA	CTD	PMID:17562736
SLCO2A1	Human	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:736967	6480464	perfluorohexanesulfonic acid results in decreased expression of SLCO2A1 mRNA	CTD	PMID:37995155
SLCO2A1	Human	perfluorononanoic acid	increases expression	EXP		6480464	perfluoro-n-nonanoic acid results in increased expression of SLCO2A1 mRNA	CTD	PMID:32588087
SLCO2A1	Human	perfluorooctane-1-sulfonic acid	increases expression	EXP		6480464	perfluorooctane sulfonic acid results in increased expression of SLCO2A1 mRNA	CTD	PMID:32588087
SLCO2A1	Human	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:736967	6480464	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SLCO2A1 mRNA	CTD	PMID:36331819
SLCO2A1	Human	perfluorooctanoic acid	increases expression	EXP		6480464	perfluorooctanoic acid results in increased expression of SLCO2A1 mRNA	CTD	PMID:32588087
SLCO2A1	Human	permethrin	multiple interactions	ISO	RGD:3051	6480464	[Permethrin co-treated with DEET] results in decreased methylation of SLCO2A1 gene	CTD	PMID:33148267
SLCO2A1	Human	phenobarbital	decreases expression	ISO	RGD:736967	6480464	Phenobarbital results in decreased expression of SLCO2A1 mRNA	CTD	PMID:19482888
SLCO2A1	Human	phenobarbital	increases expression	EXP		6480464	Phenobarbital results in increased expression of SLCO2A1 mRNA	CTD	PMID:19084549
SLCO2A1	Human	phenobarbital	multiple interactions	ISO	RGD:736967	6480464	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of SLCO2A1 mRNA; NR1I3 protein affects the more ...	CTD	PMID:19482888\|PMID:24535843
SLCO2A1	Human	pirinixic acid	increases expression	ISO	RGD:3051	6480464	pirinixic acid results in increased expression of SLCO2A1 mRNA	CTD	PMID:19162173
SLCO2A1	Human	pirinixic acid	decreases expression	ISO	RGD:736967	6480464	pirinixic acid results in decreased expression of SLCO2A1 mRNA	CTD	PMID:17426115\|PMID:23811191
SLCO2A1	Human	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:736967	6480464	Pregnenolone Carbonitrile results in decreased expression of SLCO2A1 mRNA	CTD	PMID:15919853
SLCO2A1	Human	progesterone	multiple interactions	EXP		6480464	[Estradiol co-treated with Progesterone] results in decreased expression of SLCO2A1 mRNA; Mifepristone promotes the reaction more ...	CTD	PMID:20660070\|PMID:22414680
SLCO2A1	Human	progesterone	decreases expression	ISO	RGD:736967	6480464	Progesterone results in decreased expression of SLCO2A1 mRNA	CTD	PMID:22238285
SLCO2A1	Human	prostaglandin E2	multiple interactions	EXP		6480464	Diclofenac inhibits the reaction [SLCO2A1 protein results in increased transport of Dinoprostone]; Indomethacin promotes the more ...	CTD	PMID:19843975
SLCO2A1	Human	prostaglandin E2	increases transport	EXP		6480464	SLCO2A1 protein results in increased transport of Dinoprostone	CTD	PMID:19843975
SLCO2A1	Human	quercetin	increases uptake	EXP		6480464	SLCO2A1 protein results in increased uptake of Quercetin	CTD	PMID:24947867
SLCO2A1	Human	resveratrol	increases expression	EXP		6480464	resveratrol results in increased expression of SLCO2A1 mRNA	CTD	PMID:19371625
SLCO2A1	Human	rifampicin	multiple interactions	EXP		6480464	Rifampin inhibits the reaction [decitabine results in increased expression of SLCO2A1 mRNA]	CTD	PMID:23137910
SLCO2A1	Human	sodium arsenite	increases expression	EXP		6480464	sodium arsenite results in increased expression of SLCO2A1 mRNA	CTD	PMID:29301061\|PMID:32844245\|PMID:34032870
SLCO2A1	Human	sodium arsenite	increases expression	ISO	RGD:736967	6480464	sodium arsenite results in increased expression of SLCO2A1 mRNA	CTD	PMID:36209798
SLCO2A1	Human	sodium arsenite	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
SLCO2A1	Human	sodium arsenite	decreases expression	EXP		6480464	sodium arsenite results in decreased expression of SLCO2A1 mRNA	CTD	PMID:38568856
SLCO2A1	Human	sodium arsenite	decreases methylation	EXP		6480464	sodium arsenite results in decreased methylation of SLCO2A1 exon	CTD	PMID:32844245
SLCO2A1	Human	sodium fluoride	increases expression	ISO	RGD:736967	6480464	Sodium Fluoride results in increased expression of SLCO2A1 mRNA	CTD	PMID:27862939
SLCO2A1	Human	spironolactone	decreases expression	ISO	RGD:736967	6480464	Spironolactone results in decreased expression of SLCO2A1 mRNA	CTD	PMID:15919853
SLCO2A1	Human	sulforaphane	decreases expression	EXP		6480464	sulforaphane results in decreased expression of SLCO2A1 mRNA	CTD	PMID:31838189
SLCO2A1	Human	sunitinib	increases expression	EXP		6480464	Sunitinib results in increased expression of SLCO2A1 mRNA	CTD	PMID:31533062
SLCO2A1	Human	tamoxifen	decreases expression	ISO	RGD:736967	6480464	Tamoxifen results in decreased expression of SLCO2A1 mRNA	CTD	PMID:25123088
SLCO2A1	Human	tetrachloromethane	affects expression	ISO	RGD:736967	6480464	Carbon Tetrachloride affects the expression of SLCO2A1 mRNA	CTD	PMID:17484886
SLCO2A1	Human	tetrachloromethane	multiple interactions	ISO	RGD:736967	6480464	[PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of SLCO2A1 mRNA	CTD	PMID:29987408
SLCO2A1	Human	tetrachloromethane	decreases expression	ISO	RGD:3051	6480464	Carbon Tetrachloride results in decreased expression of SLCO2A1 mRNA	CTD	PMID:31150632
SLCO2A1	Human	tetrachloromethane	multiple interactions	ISO	RGD:3051	6480464	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLCO2A1 mRNA]	CTD	PMID:31150632
SLCO2A1	Human	thioacetamide	decreases expression	ISO	RGD:3051	6480464	Thioacetamide results in decreased expression of SLCO2A1 mRNA	CTD	PMID:23411599
SLCO2A1	Human	thiram	decreases expression	EXP		6480464	Thiram results in decreased expression of SLCO2A1 mRNA	CTD	PMID:38568856
SLCO2A1	Human	titanium dioxide	decreases methylation	ISO	RGD:736967	6480464	titanium dioxide results in decreased methylation of SLCO2A1 promoter	CTD	PMID:35295148
SLCO2A1	Human	trichloroethene	decreases expression	ISO	RGD:736967	6480464	Trichloroethylene results in decreased expression of SLCO2A1 mRNA	CTD	PMID:25549359
SLCO2A1	Human	triclosan	decreases expression	EXP		6480464	Triclosan results in decreased expression of SLCO2A1 mRNA	CTD	PMID:30510588
SLCO2A1	Human	Triptolide	increases expression	ISO	RGD:3051	6480464	triptolide results in increased expression of SLCO2A1 protein	CTD	PMID:32519852
SLCO2A1	Human	triptonide	increases expression	ISO	RGD:736967	6480464	triptonide results in increased expression of SLCO2A1 mRNA	CTD	PMID:33045310
SLCO2A1	Human	tunicamycin	increases expression	EXP		6480464	Tunicamycin results in increased expression of SLCO2A1 mRNA	CTD	PMID:29453283
SLCO2A1	Human	valdecoxib	decreases expression	ISO	RGD:3051	6480464	valdecoxib results in decreased expression of SLCO2A1 mRNA	CTD	PMID:24136188
SLCO2A1	Human	valproic acid	increases expression	ISO	RGD:3051	6480464	Valproic Acid results in increased expression of SLCO2A1 mRNA	CTD	PMID:32437819
SLCO2A1	Human	valproic acid	decreases expression	ISO	RGD:3051	6480464	Valproic Acid results in decreased expression of SLCO2A1 mRNA	CTD	PMID:32437819
SLCO2A1	Human	vinclozolin	affects expression	ISO	RGD:3051	6480464	vinclozolin affects the expression of SLCO2A1 mRNA	CTD	PMID:19015723
SLCO2A1	Human	zidovudine	decreases expression	EXP		6480464	Zidovudine results in decreased expression of SLCO2A1 mRNA	CTD	PMID:24292225
SLCO2A1	Human	zoledronic acid	increases expression	EXP		6480464	zoledronic acid results in increased expression of SLCO2A1 mRNA	CTD	PMID:24714768

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2A1	Human	lipid transport	involved_in	IEA	UniProtKB-KW:KW-0445	150520179		UniProt	GO_REF:0000043
SLCO2A1	Human	lipid transport	involved_in	TAS		150520179	PMID:8787677	PINC	PMID:8787677
SLCO2A1	Human	monoatomic ion transport	involved_in	IEA	UniProtKB-KW:KW-0406	150520179		UniProt	GO_REF:0000043
SLCO2A1	Human	prostaglandin transport	acts_upstream_of_or_within	IEA	UniProtKB:Q9EPT5\|ensembl:ENSMUSP00000035148	150520179		Ensembl	GO_REF:0000107
SLCO2A1	Human	prostaglandin transport	involved_in	IBA	MGI:1346021\|PANTHER:PTN002604696	150520179		GO_Central	GO_REF:0000033
SLCO2A1	Human	sodium-independent organic anion transport	involved_in	TAS		150520179		Reactome	Reactome:R-HSA-879518
SLCO2A1	Human	sodium-independent organic anion transport	involved_in	IBA	PANTHER:PTN002261135\|RGD:621389	150520179		GO_Central	GO_REF:0000033
SLCO2A1	Human	transmembrane transport	involved_in	IEA	InterPro:IPR004156	150520179		InterPro	GO_REF:0000002

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2A1	Human	basal plasma membrane	located_in	IDA		150520179	PMID:35307651	UniProt	PMID:35307651
SLCO2A1	Human	basal plasma membrane	located_in	IEA	UniProtKB-SubCell:SL-0024	150520179		UniProt	GO_REF:0000044
SLCO2A1	Human	basolateral plasma membrane	is_active_in	IBA	FB:FBgn0032123\|FB:FBgn0034715\|FB:FBgn0034716\|MGI:1351891\|MGI:1889679\|PANTHER:PTN002261135\|RGD:1303048\|RGD:628660\|RGD:69300\|UniProtKB:Q9NYB5	150520179		GO_Central	GO_REF:0000033
SLCO2A1	Human	cytoplasm	located_in	IEA	UniProtKB-SubCell:SL-0086	150520179		UniProt	GO_REF:0000044
SLCO2A1	Human	cytoplasm	located_in	IEA	UniProtKB-KW:KW-0963	150520179		UniProt	GO_REF:0000043
SLCO2A1	Human	lysosome	located_in	IEA	UniProtKB-SubCell:SL-0158	150520179		UniProt	GO_REF:0000044
SLCO2A1	Human	lysosome	located_in	IEA	UniProtKB-KW:KW-0458	150520179		UniProt	GO_REF:0000043
SLCO2A1	Human	membrane	located_in	IEA	UniProtKB-KW:KW-0472	150520179		UniProt	GO_REF:0000043
SLCO2A1	Human	membrane	located_in	IEA	UniProtKB-SubCell:SL-0162	150520179		UniProt	GO_REF:0000044
SLCO2A1	Human	membrane	located_in	TAS		150520179	PMID:8787677	PINC	PMID:8787677
SLCO2A1	Human	membrane	located_in	IEA	InterPro:IPR004156	150520179		InterPro	GO_REF:0000002
SLCO2A1	Human	plasma membrane	located_in	IEA	UniProtKB-KW:KW-1003	150520179		UniProt	GO_REF:0000043
SLCO2A1	Human	plasma membrane	located_in	TAS		150520179	PMID:8787677	PINC	PMID:8787677\|Reactome:R-HSA-5661188\|Reactome:R-HSA-879528
SLCO2A1	Human	plasma membrane	located_in	IEA	UniProtKB-SubCell:SL-0039	150520179		UniProt	GO_REF:0000044

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2A1	Human	lipid transporter activity	enables	TAS		150520179	PMID:8787677	PINC	PMID:8787677
SLCO2A1	Human	prostaglandin transmembrane transporter activity	enables	TAS		150520179		Reactome	Reactome:R-HSA-5661188\|Reactome:R-HSA-879528
SLCO2A1	Human	prostaglandin transmembrane transporter activity	enables	IBA	MGI:1346021\|PANTHER:PTN002604696	150520179		GO_Central	GO_REF:0000033
SLCO2A1	Human	prostaglandin transmembrane transporter activity	enables	IEA	UniProtKB:Q9EPT5\|ensembl:ENSMUSP00000035148	150520179		Ensembl	GO_REF:0000107
SLCO2A1	Human	sodium-independent organic anion transmembrane transporter activity	enables	IBA	PANTHER:PTN002261135\|RGD:621391\|UniProtKB:O94956	150520179		GO_Central	GO_REF:0000033
SLCO2A1	Human	transmembrane transporter activity	enables	IEA	InterPro:IPR020846	150520179		InterPro	GO_REF:0000002

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2A1	Human	Abnormal bone marrow cell morphology		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Abnormal cortical bone morphology		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Abnormal epiphysis morphology		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Abnormal fingernail morphology		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Abnormal hair pattern		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Abnormal hair quantity		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Acne		IAGP		8699517		HPO	MIM:167100\|PMID:23509104\|MIM:614441\|PMID:23509104\|ORPHA:2796
SLCO2A1	Human	Anemia		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Arthralgia		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Arthritis		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Autosomal dominant inheritance		IAGP		8699517		HPO	MIM:167100
SLCO2A1	Human	Autosomal recessive inheritance		IAGP		8699517		HPO	MIM:614441\|PMID:23509104
SLCO2A1	Human	Avascular necrosis		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Bone pain		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Cerebral palsy		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Clubbing		IAGP		8699517		HPO	MIM:614441\|PMID:23509104
SLCO2A1	Human	Clubbing of fingers		IAGP		8699517		HPO	MIM:167100\|PMID:24838973
SLCO2A1	Human	Clubbing of toes		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Coarse facial features		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Cutis gyrata of scalp		IAGP		8699517		HPO	MIM:167100\|ORPHA:2796
SLCO2A1	Human	Eczematoid dermatitis		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Edema		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Elevated circulating growth hormone concentration		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Elevated urinary prostaglandin E2 level		IAGP		8699517		HPO	MIM:167100\|PMID:24838973
SLCO2A1	Human	Gastrointestinal hemorrhage		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Genu varum		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Gynecomastia		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Hepatomegaly		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Hyperhidrosis		IAGP		8699517		HPO	MIM:167100\|PMID:23509104\|MIM:614441\|PMID:23509104\|ORPHA:2796
SLCO2A1	Human	Hyperostosis		IAGP		8699517		HPO	MIM:614441
SLCO2A1	Human	Hypoalbuminemia		IAGP		8699517		HPO	MIM:614441\|PMID:23509104
SLCO2A1	Human	Impaired temperature sensation		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Joint swelling		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Juvenile onset		IAGP		8699517		HPO	MIM:614441\|PMID:23509104
SLCO2A1	Human	Knee pain		IAGP		8699517		HPO	MIM:167100\|PMID:23509104\|MIM:614441\|PMID:23509104
SLCO2A1	Human	Limitation of joint mobility		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Malabsorption		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Neoplasm of the lung		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Neoplasm of the skin		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Osteolysis		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Osteomyelitis		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Osteoporosis		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Palmoplantar keratoderma		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Peptic ulcer		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Periosteal thickening of long tubular bones		IAGP		8699517		HPO	MIM:167100\|PMID:23509104
SLCO2A1	Human	Periostosis		IAGP		8699517		HPO	MIM:614441
SLCO2A1	Human	Ptosis		IAGP		8699517		HPO	MIM:167100\|ORPHA:2796
SLCO2A1	Human	Scoliosis		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Seborrheic dermatitis		IAGP		8699517		HPO	MIM:167100\|PMID:23509104\|MIM:614441\|PMID:23509104\|ORPHA:2796
SLCO2A1	Human	Secretory diarrhea		IAGP		8699517		HPO	MIM:167100\|PMID:23509104\|MIM:614441\|PMID:23509104
SLCO2A1	Human	Small hand		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Splenomegaly		IAGP		8699517		HPO	ORPHA:2796
SLCO2A1	Human	Thickened skin		IAGP		8699517		HPO	MIM:167100\|PMID:23509104\|MIM:614441\|PMID:23509104\|ORPHA:2796
SLCO2A1	Human	Young adult onset		IAGP		8699517		HPO	MIM:167100\|PMID:23509104\|MIM:614441\|PMID:23509104

#	Reference Title	Reference Citation
1.	GOAs Human GO annotations	GOA_HUMAN data from the GO Consortium
2.	OMIM Disease Annotation Pipeline	OMIM Disease Annotation Pipeline
3.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
4.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions
5.	RGD HPO Phenotype Annotation Pipeline	RGD automated import pipeline for human HPO-to-gene-to-disease annotations

PMID:8787677	PMID:9618293	PMID:9832484	PMID:12477932	PMID:14579113	PMID:15864125	PMID:16339169	PMID:16344560	PMID:17474147	PMID:18353443	PMID:18976975	PMID:19138942
PMID:20346915	PMID:20357271	PMID:20424473	PMID:21873635	PMID:22060278	PMID:22197487	PMID:22331663	PMID:22553128	PMID:22696055	PMID:22906430	PMID:23509104	PMID:24153155
PMID:24185079	PMID:24694755	PMID:24838973	PMID:24929850	PMID:25059581	PMID:25433165	PMID:25433169	PMID:25810087	PMID:26265282	PMID:26464663	PMID:26539716	PMID:26692285
PMID:26850138	PMID:27134495	PMID:27336732	PMID:27467110	PMID:27681482	PMID:28602931	PMID:28783044	PMID:30400730	PMID:31004291	PMID:31196708	PMID:33166338	PMID:33397021
PMID:33619025	PMID:35299026	PMID:35307651	PMID:35611666	PMID:35877192	PMID:36549465	PMID:36706979	PMID:36731680	PMID:36907595	PMID:37327083	PMID:37861627	PMID:37906648
PMID:37915296	PMID:38644096	PMID:38755710

SLCO2A1
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	3	133,932,701 - 134,029,925 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	3	133,932,701 - 134,052,184 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	3	133,651,545 - 133,748,769 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	3	135,134,230 - 135,231,418 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	3	135,134,239 - 135,231,426	NCBI
Celera	3	132,077,395 - 132,174,290 (-)	NCBI		Celera
Cytogenetic Map	3	q22.1-q22.2	NCBI
HuRef	3	131,029,670 - 131,126,922 (-)	NCBI		HuRef
CHM1_1	3	133,615,353 - 133,712,732 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	3	136,677,860 - 136,775,063 (-)	NCBI		T2T-CHM13v2.0

Slco2a1
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	9	102,885,686 - 102,973,201 (+)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	9	102,865,911 - 102,973,201 (+)	Ensembl		GRCm39 Ensembl
GRCm38	9	103,007,061 - 103,096,002 (+)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	9	102,988,712 - 103,096,002 (+)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	9	102,910,819 - 102,990,179 (+)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	9	102,866,770 - 102,944,916 (+)	NCBI		MGSCv36	mm8
Celera	9	102,558,775 - 102,638,236 (+)	NCBI		Celera
Cytogenetic Map	9	F1	NCBI
cM Map	9	54.72	NCBI

Slco2a1
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	8	112,467,739 - 112,551,923 (+)	NCBI		GRCr8
mRatBN7.2	8	103,588,916 - 103,672,546 (+)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	8	103,588,916 - 103,672,546 (+)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	8	109,252,126 - 109,332,029 (+)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	8	107,451,296 - 107,531,195 (+)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	8	105,293,972 - 105,373,875 (+)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	8	111,495,443 - 111,577,320 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	8	111,495,331 - 111,577,833 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	8	110,886,314 - 110,968,548 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	8	108,012,829 - 108,098,561 (+)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
RGSC_v3.1	8	108,032,283 - 108,118,016 (+)	NCBI
Celera	8	102,966,792 - 103,051,202 (+)	NCBI		Celera
Cytogenetic Map	8	q32	NCBI

Slco2a1
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955501	4,543,194 - 4,625,715 (+)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955501	4,544,065 - 4,623,615 (+)	NCBI	ChiLan1.0	ChiLan1.0

SLCO2A1
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	2	131,856,980 - 131,954,728 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	3	131,861,709 - 131,959,457 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	3	130,978,103 - 131,075,786 (-)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	3	138,452,986 - 138,549,782 (-)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	3	138,454,881 - 138,549,785 (-)	Ensembl	panpan1.1		panPan2

SLCO2A1
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	23	30,797,956 - 30,877,340 (-)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	23	30,797,890 - 30,877,340 (-)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	23	30,777,043 - 30,856,125 (-)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	23	31,316,928 - 31,398,369 (-)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	23	31,318,754 - 31,398,430 (-)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	23	31,012,180 - 31,091,151 (-)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	23	31,069,931 - 31,148,746 (-)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	23	31,317,639 - 31,396,502 (-)	NCBI		UU_Cfam_GSD_1.0

Slco2a1
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024405602	70,308,469 - 70,395,441 (-)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936529	7,068,970 - 7,155,950 (-)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936529	7,069,003 - 7,155,229 (-)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

SLCO2A1
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	13	75,106,607 - 75,190,022 (-)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	13	75,108,540 - 75,189,660 (-)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	13	82,607,281 - 82,614,511 (-)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3
Sscrofa10.2	13	82,682,287 - 82,806,558 (+)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

SLCO2A1
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	15	56,339,585 - 56,427,196 (+)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	15	56,339,744 - 56,430,032 (+)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666041	29,322,188 - 29,409,777 (+)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Slco2a1
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624730	10,256,799 - 10,339,827 (-)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624730	10,256,799 - 10,339,388 (-)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in SLCO2A1
303 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
NM_005630.3(SLCO2A1):c.830dup (p.Phe278fs)	duplication	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV000030778]	Chr3:133951238..133951239 [GRCh38] Chr3:133670082..133670083 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.97-1G>A	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV000023104]	Chr3:133979619 [GRCh38] Chr3:133698463 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.1634del (p.Asn545fs)	deletion	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV000023106]\|not provided [RCV005089305]	Chr3:133938485 [GRCh38] Chr3:133657329 [GRCh37] Chr3:3q22.1	pathogenic
SLCO2A1, GLY222ARG	variation	Primary hypertrophic osteoarthropathy, autosomal recessive 2 [RCV000023107]	Chr3:3q21	pathogenic
SLCO2A1, IVS7, G-A, +1	single nucleotide variant	Primary hypertrophic osteoarthropathy, autosomal recessive 2 [RCV000023108]	Chr3:3q21	pathogenic
NM_005630.3(SLCO2A1):c.861+2T>C	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal dominant [RCV001527660]\|Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003642961]	Chr3:133951206 [GRCh38] Chr3:133670050 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.764G>A (p.Gly255Glu)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV000023105]\|not provided [RCV005089304]	Chr3:133951305 [GRCh38] Chr3:133670149 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.754C>T (p.Arg252Ter)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003642868]	Chr3:133951315 [GRCh38] Chr3:133670159 [GRCh37] Chr3:3q22.1	pathogenic\|uncertain significance
NM_005630.3(SLCO2A1):c.1259G>T (p.Cys420Phe)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV000030780]\|not provided [RCV002223177]	Chr3:133947292 [GRCh38] Chr3:133666136 [GRCh37] Chr3:3q22.1	pathogenic\|likely pathogenic
NM_005630.3(SLCO2A1):c.253A>T (p.Ile85Phe)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV000030781]	Chr3:133973807 [GRCh38] Chr3:133692651 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.310G>T (p.Gly104Ter)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal dominant [RCV001527661]\|Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV000030782]\|not provided [RCV002513277]	Chr3:133973750 [GRCh38] Chr3:133692594 [GRCh37] Chr3:3q22.1	pathogenic
GRCh38/hg38 3q22.1-23(chr3:132690641-141064444)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051570]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051570]\|See cases [RCV000051570]	Chr3:132690641..141064444 [GRCh38] Chr3:132409485..140783286 [GRCh37] Chr3:133892175..142265976 [NCBI36] Chr3:3q22.1-23	pathogenic
GRCh38/hg38 3q22.1-22.3(chr3:132972567-136894498)x1	copy number loss	See cases [RCV000051571]	Chr3:132972567..136894498 [GRCh38] Chr3:132691411..136613340 [GRCh37] Chr3:134174101..138096030 [NCBI36] Chr3:3q22.1-22.3	pathogenic
GRCh38/hg38 3q13.11-29(chr3:103426882-198110178)x3	copy number gain	See cases [RCV000134948]	Chr3:103426882..198110178 [GRCh38] Chr3:103145726..197837049 [GRCh37] Chr3:104628416..199321446 [NCBI36] Chr3:3q13.11-29	pathogenic
GRCh38/hg38 3q22.1-24(chr3:129817243-143381624)x1	copy number loss	See cases [RCV000136558]	Chr3:129817243..143381624 [GRCh38] Chr3:129536086..143100466 [GRCh37] Chr3:131018776..144583156 [NCBI36] Chr3:3q22.1-24	pathogenic
GRCh38/hg38 3q22.1-23(chr3:130401265-139005019)x1	copy number loss	See cases [RCV000139240]	Chr3:130401265..139005019 [GRCh38] Chr3:130120109..138723861 [GRCh37] Chr3:131602799..140206551 [NCBI36] Chr3:3q22.1-23	pathogenic
GRCh38/hg38 3q22.1-23(chr3:129817243-141425155)x1	copy number loss	See cases [RCV000140995]	Chr3:129817243..141425155 [GRCh38] Chr3:129536086..141143997 [GRCh37] Chr3:131018776..142626687 [NCBI36] Chr3:3q22.1-23	pathogenic
GRCh38/hg38 3q21.3-23(chr3:126106779-140918089)x3	copy number gain	See cases [RCV000142010]	Chr3:126106779..140918089 [GRCh38] Chr3:125825622..140636931 [GRCh37] Chr3:127308312..142119621 [NCBI36] Chr3:3q21.3-23	uncertain significance
GRCh38/hg38 3q11.1-24(chr3:93800620-145695381)x3	copy number gain	See cases [RCV000142340]	Chr3:93800620..145695381 [GRCh38] Chr3:93519464..145413168 [GRCh37] Chr3:95002154..146895858 [NCBI36] Chr3:3q11.1-24	pathogenic
GRCh38/hg38 3q22.1-24(chr3:132716978-144784743)x1	copy number loss	See cases [RCV000143634]	Chr3:132716978..144784743 [GRCh38] Chr3:132435822..144503585 [GRCh37] Chr3:133918512..145986275 [NCBI36] Chr3:3q22.1-24	pathogenic
NM_005630.3(SLCO2A1):c.1243T>C (p.Leu415=)	single nucleotide variant	not provided [RCV000958708]	Chr3:133947308 [GRCh38] Chr3:133666152 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.1807C>T (p.Arg603Ter)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal dominant [RCV001527663]\|Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV000490280]\|not provided [RCV002517444]	Chr3:133935781 [GRCh38] Chr3:133654625 [GRCh37] Chr3:3q22.1	pathogenic\|likely pathogenic
NM_005630.3(SLCO2A1):c.940+1G>A	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV000490351]\|not provided [RCV001389437]	Chr3:133948892 [GRCh38] Chr3:133667736 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.1279_1290del (p.Glu427_Pro430del)	deletion	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV000490458]	Chr3:133947261..133947272 [GRCh38] Chr3:133666105..133666116 [GRCh37] Chr3:3q22.1	likely pathogenic
NM_005630.3(SLCO2A1):c.664G>A (p.Gly222Arg)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal dominant [RCV001527659]\|Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV000505666]\|not provided [RCV002527331]	Chr3:133953723 [GRCh38] Chr3:133672567 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.1084G>C (p.Ala362Pro)	single nucleotide variant	Inborn genetic diseases [RCV003250224]\|SLCO2A1-related disorder [RCV003973788]\|not provided [RCV005102594]	Chr3:133948557 [GRCh38] Chr3:133667401 [GRCh37] Chr3:3q22.1	benign\|likely benign\|uncertain significance
GRCh37/hg19 3p26.3-q29(chr3:61892-197851986)	copy number gain	See cases [RCV000512358]	Chr3:61892..197851986 [GRCh37] Chr3:3p26.3-q29	pathogenic
NM_005630.3(SLCO2A1):c.257T>C (p.Ile86Thr)	single nucleotide variant	Inborn genetic diseases [RCV003248081]	Chr3:133973803 [GRCh38] Chr3:133692647 [GRCh37] Chr3:3q22.1	uncertain significance
GRCh37/hg19 3p26.3-q29(chr3:61892-197851986)x3	copy number gain	See cases [RCV000511055]	Chr3:61892..197851986 [GRCh37] Chr3:3p26.3-q29	pathogenic
GRCh37/hg19 3q22.1-22.3(chr3:132642704-136360844)x1	copy number loss	Intellectual disability, autosomal dominant 47 [RCV000680253]	Chr3:132642704..136360844 [GRCh37] Chr3:3q22.1-22.3	likely pathogenic
NM_005630.3(SLCO2A1):c.397+10T>C	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal dominant [RCV001810071]\|Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001810070]\|not provided [RCV001595091]\|not specified [RCV001530003]	Chr3:133973653 [GRCh38] Chr3:133692497 [GRCh37] Chr3:3q22.1	benign
GRCh37/hg19 3p26.3-q29(chr3:61495-197838262)x3	copy number gain	not provided [RCV000742138]	Chr3:61495..197838262 [GRCh37] Chr3:3p26.3-q29	pathogenic
GRCh37/hg19 3p26.3-q29(chr3:60174-197948027)x3	copy number gain	not provided [RCV000742133]	Chr3:60174..197948027 [GRCh37] Chr3:3p26.3-q29	pathogenic
Single allele	deletion	Deafness-lymphedema-leukemia syndrome [RCV001541925]	Chr3:127966423..136853218 [GRCh37] Chr3:3q21.3-22.3	pathogenic
NM_005630.3(SLCO2A1):c.309C>T (p.Ile103=)	single nucleotide variant	not provided [RCV000940544]	Chr3:133973751 [GRCh38] Chr3:133692595 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1626-295A>G	single nucleotide variant	not provided [RCV001708540]	Chr3:133938788 [GRCh38] Chr3:133657632 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.270C>G (p.Tyr90Ter)	single nucleotide variant	not provided [RCV000760766]	Chr3:133973790 [GRCh38] Chr3:133692634 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.1186G>A (p.Ala396Thr)	single nucleotide variant	not provided [RCV001645187]	Chr3:133947365 [GRCh38] Chr3:133666209 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.495G>T (p.Glu165Asp)	single nucleotide variant	not provided [RCV000905080]	Chr3:133955096 [GRCh38] Chr3:133673940 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.618G>T (p.Leu206=)	single nucleotide variant	not provided [RCV000900714]	Chr3:133954973 [GRCh38] Chr3:133673817 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.855A>C (p.Gly285=)	single nucleotide variant	not provided [RCV000919949]	Chr3:133951214 [GRCh38] Chr3:133670058 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1691-5T>C	single nucleotide variant	not provided [RCV000892337]	Chr3:133935902 [GRCh38] Chr3:133654746 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.77C>T (p.Ser26Leu)	single nucleotide variant	SLCO2A1-related disorder [RCV003910626]\|not provided [RCV000892765]	Chr3:134029726 [GRCh38] Chr3:133748570 [GRCh37] Chr3:3q22.2	benign\|likely benign
NM_005630.3(SLCO2A1):c.1291C>A (p.Pro431Thr)	single nucleotide variant	SLCO2A1-related disorder [RCV003955851]\|not provided [RCV000882598]	Chr3:133947260 [GRCh38] Chr3:133666104 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1370C>T (p.Pro457Leu)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003316898]	Chr3:133945186 [GRCh38] Chr3:133664030 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.862-6C>T	single nucleotide variant	not provided [RCV000961476]	Chr3:133948977 [GRCh38] Chr3:133667821 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1755G>A (p.Ser585=)	single nucleotide variant	not provided [RCV000970825]	Chr3:133935833 [GRCh38] Chr3:133654677 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.657G>A (p.Pro219=)	single nucleotide variant	not provided [RCV000981812]	Chr3:133953730 [GRCh38] Chr3:133672574 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.1020C>T (p.Ser340=)	single nucleotide variant	not provided [RCV000902786]	Chr3:133948621 [GRCh38] Chr3:133667465 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.1288C>T (p.Pro430Ser)	single nucleotide variant	SLCO2A1-related disorder [RCV003960553]\|not provided [RCV000943095]	Chr3:133947263 [GRCh38] Chr3:133666107 [GRCh37] Chr3:3q22.1	benign\|likely benign
NM_005630.3(SLCO2A1):c.1657A>G (p.Ile553Val)	single nucleotide variant	not provided [RCV000908797]	Chr3:133938462 [GRCh38] Chr3:133657306 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1166G>A (p.Arg389His)	single nucleotide variant	not provided [RCV000903272]	Chr3:133947385 [GRCh38] Chr3:133666229 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.736T>C (p.Leu246=)	single nucleotide variant	not provided [RCV000940375]	Chr3:133951333 [GRCh38] Chr3:133670177 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1923C>T (p.Gly641=)	single nucleotide variant	not provided [RCV000962056]	Chr3:133934722 [GRCh38] Chr3:133653566 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.1812C>T (p.Asp604=)	single nucleotide variant	not provided [RCV000919234]	Chr3:133935776 [GRCh38] Chr3:133654620 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.81C>G (p.Val27=)	single nucleotide variant	not provided [RCV000922205]	Chr3:134029722 [GRCh38] Chr3:133748566 [GRCh37] Chr3:3q22.2	likely benign
NM_005630.3(SLCO2A1):c.1440C>T (p.Ser480=)	single nucleotide variant	not provided [RCV000976618]	Chr3:133945116 [GRCh38] Chr3:133663960 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.86del (p.Gly29fs)	deletion	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001029816]	Chr3:134029717 [GRCh38] Chr3:133748561 [GRCh37] Chr3:3q22.2	likely pathogenic
GRCh37/hg19 3q22.1(chr3:133588698-133662948)x3	copy number gain	not provided [RCV000846541]	Chr3:133588698..133662948 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.290G>A (p.Arg97His)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001198034]	Chr3:133973770 [GRCh38] Chr3:133692614 [GRCh37] Chr3:3q22.1	likely pathogenic
NM_005630.3(SLCO2A1):c.1016C>T (p.Ser339Phe)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV004813497]	Chr3:133948625 [GRCh38] Chr3:133667469 [GRCh37] Chr3:3q22.1	likely pathogenic
NM_005630.3(SLCO2A1):c.1691-105C>T	single nucleotide variant	not provided [RCV001533789]	Chr3:133936002 [GRCh38] Chr3:133654846 [GRCh37] Chr3:3q22.1	benign
NC_000003.12:g.134030188C>G	single nucleotide variant	not provided [RCV001639879]	Chr3:134030188 [GRCh38] Chr3:133749032 [GRCh37] Chr3:3q22.2	benign
NM_005630.3(SLCO2A1):c.235-74G>A	single nucleotide variant	not provided [RCV001669916]	Chr3:133973899 [GRCh38] Chr3:133692743 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.1461+258T>C	single nucleotide variant	not provided [RCV001682610]	Chr3:133944837 [GRCh38] Chr3:133663681 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.1625+97C>A	single nucleotide variant	not provided [RCV001724696]	Chr3:133942508 [GRCh38] Chr3:133661352 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.234+45G>C	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal dominant [RCV001810288]\|Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001810287]\|not provided [RCV001714936]	Chr3:133979436 [GRCh38] Chr3:133698280 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.1333C>T (p.Arg445Cys)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001029821]\|SLCO2A1-related disorder [RCV003903257]\|not provided [RCV000954250]	Chr3:133945223 [GRCh38] Chr3:133664067 [GRCh37] Chr3:3q22.1	benign\|likely benign\|uncertain significance
NM_005630.3(SLCO2A1):c.174C>T (p.Thr58=)	single nucleotide variant	not provided [RCV000885306]	Chr3:133979541 [GRCh38] Chr3:133698385 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.573G>A (p.Gly191=)	single nucleotide variant	not provided [RCV000918832]	Chr3:133955018 [GRCh38] Chr3:133673862 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.672G>A (p.Leu224=)	single nucleotide variant	not provided [RCV000883774]	Chr3:133953715 [GRCh38] Chr3:133672559 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.1581G>C (p.Leu527=)	single nucleotide variant	SLCO2A1-related disorder [RCV003932931]\|not provided [RCV000908104]	Chr3:133942649 [GRCh38] Chr3:133661493 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1797C>T (p.Asn599=)	single nucleotide variant	not provided [RCV000908695]	Chr3:133935791 [GRCh38] Chr3:133654635 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.1905C>T (p.Asn635=)	single nucleotide variant	not provided [RCV000917398]	Chr3:133934740 [GRCh38] Chr3:133653584 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.484C>G (p.Pro162Ala)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001335307]\|not provided [RCV000902042]	Chr3:133955107 [GRCh38] Chr3:133673951 [GRCh37] Chr3:3q22.1	likely benign\|uncertain significance
NM_005630.3(SLCO2A1):c.1385A>G (p.Asn462Ser)	single nucleotide variant	not provided [RCV000962985]	Chr3:133945171 [GRCh38] Chr3:133664015 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.682G>A (p.Val228Ile)	single nucleotide variant	SLCO2A1-related disorder [RCV003923100]\|not provided [RCV000907656]	Chr3:133953705 [GRCh38] Chr3:133672549 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.367G>A (p.Glu123Lys)	single nucleotide variant	SLCO2A1-related disorder [RCV003923197]\|not provided [RCV000913911]	Chr3:133973693 [GRCh38] Chr3:133692537 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1691-260C>T	single nucleotide variant	not provided [RCV001596539]	Chr3:133936157 [GRCh38] Chr3:133655001 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.234+1G>A	single nucleotide variant	not provided [RCV001561613]	Chr3:133979480 [GRCh38] Chr3:133698324 [GRCh37] Chr3:3q22.1	likely pathogenic
GRCh37/hg19 3q13.31-26.31(chr3:116620308-172042292)x3	copy number gain	not provided [RCV002472621]	Chr3:116620308..172042292 [GRCh37] Chr3:3q13.31-26.31	pathogenic
NM_005630.3(SLCO2A1):c.1461+105AC[6]	microsatellite	not provided [RCV001650177]	Chr3:133944980..133944981 [GRCh38] Chr3:133663824..133663825 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.1237_1246del (p.Val413fs)	deletion	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001533517]	Chr3:133947305..133947314 [GRCh38] Chr3:133666149..133666158 [GRCh37] Chr3:3q22.1	likely pathogenic
NM_005630.3(SLCO2A1):c.397+314A>C	single nucleotide variant	not provided [RCV001667269]	Chr3:133973349 [GRCh38] Chr3:133692193 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.840A>G (p.Arg280=)	single nucleotide variant	not provided [RCV001652196]	Chr3:133951229 [GRCh38] Chr3:133670073 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.725-203T>G	single nucleotide variant	not provided [RCV001649865]	Chr3:133951547 [GRCh38] Chr3:133670391 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.96+218GT[10]	microsatellite	not provided [RCV001651843]	Chr3:134029473..134029474 [GRCh38] Chr3:133748317..133748318 [GRCh37] Chr3:3q22.2	benign
NM_005630.3(SLCO2A1):c.940+91G>A	single nucleotide variant	not provided [RCV001714044]	Chr3:133948802 [GRCh38] Chr3:133667646 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.1106-1G>C	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001029822]	Chr3:133947446 [GRCh38] Chr3:133666290 [GRCh37] Chr3:3q22.1	likely pathogenic
NM_005630.3(SLCO2A1):c.1524del (p.Val509fs)	deletion	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001255883]	Chr3:133942706 [GRCh38] Chr3:133661550 [GRCh37] Chr3:3q22.1	likely pathogenic
NM_005630.3(SLCO2A1):c.547G>A (p.Gly183Arg)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001255886]\|not provided [RCV001879945]	Chr3:133955044 [GRCh38] Chr3:133673888 [GRCh37] Chr3:3q22.1	pathogenic\|likely pathogenic
NM_005630.3(SLCO2A1):c.830del (p.Phe277fs)	deletion	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001255885]	Chr3:133951239 [GRCh38] Chr3:133670083 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.725-37A>G	single nucleotide variant	not provided [RCV001641986]	Chr3:133951381 [GRCh38] Chr3:133670225 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.398-5T>C	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001255884]	Chr3:133955198 [GRCh38] Chr3:133674042 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1931G>C (p.Ter644Ser)	single nucleotide variant	not provided [RCV001957827]	Chr3:133934714 [GRCh38] Chr3:133653558 [GRCh37] Chr3:3q22.1	pathogenic\|uncertain significance
NM_005630.3(SLCO2A1):c.621C>A (p.Tyr207Ter)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001527664]	Chr3:133954970 [GRCh38] Chr3:133673814 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.1660G>A (p.Gly554Arg)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal dominant [RCV001527665]\|Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001527666]\|not provided [RCV003558833]	Chr3:133938459 [GRCh38] Chr3:133657303 [GRCh37] Chr3:3q22.1	pathogenic\|likely pathogenic
NM_005630.3(SLCO2A1):c.1814+1G>A	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001527667]	Chr3:133935773 [GRCh38] Chr3:133654617 [GRCh37] Chr3:3q22.1	pathogenic\|likely pathogenic
NM_005630.3(SLCO2A1):c.614C>T (p.Pro205Leu)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001533515]	Chr3:133954977 [GRCh38] Chr3:133673821 [GRCh37] Chr3:3q22.1	likely pathogenic
NM_005630.3(SLCO2A1):c.529C>T (p.Gln177Ter)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV001533516]	Chr3:133955062 [GRCh38] Chr3:133673906 [GRCh37] Chr3:3q22.1	likely pathogenic
NM_005630.3(SLCO2A1):c.302T>G (p.Ile101Ser)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal dominant [RCV001527662]	Chr3:133973758 [GRCh38] Chr3:133692602 [GRCh37] Chr3:3q22.1	pathogenic
NC_000003.12:g.134030326T>G	single nucleotide variant	not provided [RCV001652110]	Chr3:134030326 [GRCh38] Chr3:133749170 [GRCh37] Chr3:3q22.2	benign
NM_005630.3(SLCO2A1):c.1106-214G>A	single nucleotide variant	not provided [RCV001655129]	Chr3:133947659 [GRCh38] Chr3:133666503 [GRCh37] Chr3:3q22.1	benign
NC_000003.12:g.134029945T>C	single nucleotide variant	not provided [RCV001708915]	Chr3:134029945 [GRCh38] Chr3:133748789 [GRCh37] Chr3:3q22.2	benign
NM_005630.3(SLCO2A1):c.834C>T (p.Phe278=)	single nucleotide variant	not provided [RCV003108733]	Chr3:133951235 [GRCh38] Chr3:133670079 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1370C>G (p.Pro457Arg)	single nucleotide variant	not provided [RCV001755458]	Chr3:133945186 [GRCh38] Chr3:133664030 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1625G>A (p.Arg542His)	single nucleotide variant	not provided [RCV001757464]	Chr3:133942605 [GRCh38] Chr3:133661449 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.744G>A (p.Pro248=)	single nucleotide variant	SLCO2A1-related disorder [RCV004731218]\|not provided [RCV001964269]	Chr3:133951325 [GRCh38] Chr3:133670169 [GRCh37] Chr3:3q22.1	likely benign\|uncertain significance
NM_005630.3(SLCO2A1):c.1279G>A (p.Glu427Lys)	single nucleotide variant	not provided [RCV001970772]	Chr3:133947272 [GRCh38] Chr3:133666116 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1516T>A (p.Ser506Thr)	single nucleotide variant	not provided [RCV001929602]	Chr3:133942714 [GRCh38] Chr3:133661558 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.640A>T (p.Ile214Phe)	single nucleotide variant	not provided [RCV002025283]	Chr3:133953747 [GRCh38] Chr3:133672591 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.74G>T (p.Arg25Leu)	single nucleotide variant	not provided [RCV002022257]	Chr3:134029729 [GRCh38] Chr3:133748573 [GRCh37] Chr3:3q22.2	uncertain significance
NM_005630.3(SLCO2A1):c.1291C>G (p.Pro431Ala)	single nucleotide variant	not provided [RCV001988014]	Chr3:133947260 [GRCh38] Chr3:133666104 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.398-9T>G	single nucleotide variant	not provided [RCV002008505]	Chr3:133955202 [GRCh38] Chr3:133674046 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.332G>A (p.Gly111Asp)	single nucleotide variant	Inborn genetic diseases [RCV004044054]\|not provided [RCV001914142]	Chr3:133973728 [GRCh38] Chr3:133692572 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1755G>T (p.Ser585=)	single nucleotide variant	not provided [RCV001983116]	Chr3:133935833 [GRCh38] Chr3:133654677 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.234G>A (p.Glu78=)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV002052131]	Chr3:133979481 [GRCh38] Chr3:133698325 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1154T>C (p.Ile385Thr)	single nucleotide variant	not provided [RCV001968412]	Chr3:133947397 [GRCh38] Chr3:133666241 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1783G>A (p.Ala595Thr)	single nucleotide variant	not provided [RCV001946204]	Chr3:133935805 [GRCh38] Chr3:133654649 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1166G>T (p.Arg389Leu)	single nucleotide variant	not provided [RCV002024037]	Chr3:133947385 [GRCh38] Chr3:133666229 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1798G>A (p.Asp600Asn)	single nucleotide variant	not provided [RCV001928837]	Chr3:133935790 [GRCh38] Chr3:133654634 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1196G>A (p.Arg399His)	single nucleotide variant	not provided [RCV001946082]	Chr3:133947355 [GRCh38] Chr3:133666199 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.133C>T (p.Gln45Ter)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV002052072]	Chr3:133979582 [GRCh38] Chr3:133698426 [GRCh37] Chr3:3q22.1	likely pathogenic
NM_005630.3(SLCO2A1):c.310G>A (p.Gly104Arg)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003642981]\|not provided [RCV002042148]	Chr3:133973750 [GRCh38] Chr3:133692594 [GRCh37] Chr3:3q22.1	pathogenic\|likely pathogenic\|uncertain significance
NM_005630.3(SLCO2A1):c.295C>T (p.Arg99Cys)	single nucleotide variant	not provided [RCV001909705]	Chr3:133973765 [GRCh38] Chr3:133692609 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.572G>C (p.Gly191Ala)	single nucleotide variant	not provided [RCV001996774]	Chr3:133955019 [GRCh38] Chr3:133673863 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1115A>G (p.Asn372Ser)	single nucleotide variant	not provided [RCV001888044]	Chr3:133947436 [GRCh38] Chr3:133666280 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1837T>C (p.Tyr613His)	single nucleotide variant	not provided [RCV001992509]	Chr3:133934808 [GRCh38] Chr3:133653652 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.185G>A (p.Arg62His)	single nucleotide variant	not provided [RCV002028599]	Chr3:133979530 [GRCh38] Chr3:133698374 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.209C>T (p.Ser70Leu)	single nucleotide variant	not provided [RCV002029896]	Chr3:133979506 [GRCh38] Chr3:133698350 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1844C>T (p.Ala615Val)	single nucleotide variant	not provided [RCV001887500]	Chr3:133934801 [GRCh38] Chr3:133653645 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1690+6T>C	single nucleotide variant	not provided [RCV001897426]	Chr3:133938423 [GRCh38] Chr3:133657267 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1815-2A>T	single nucleotide variant	not provided [RCV002000667]	Chr3:133934832 [GRCh38] Chr3:133653676 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1691-10C>A	single nucleotide variant	not provided [RCV001989847]	Chr3:133935907 [GRCh38] Chr3:133654751 [GRCh37] Chr3:3q22.1	likely benign\|uncertain significance
NM_005630.3(SLCO2A1):c.1264_1265del (p.Thr422fs)	deletion	not provided [RCV001937176]	Chr3:133947286..133947287 [GRCh38] Chr3:133666130..133666131 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.1165C>T (p.Arg389Cys)	single nucleotide variant	not provided [RCV001952216]	Chr3:133947386 [GRCh38] Chr3:133666230 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.409C>T (p.Arg137Cys)	single nucleotide variant	Inborn genetic diseases [RCV004043557]\|not provided [RCV001936024]	Chr3:133955182 [GRCh38] Chr3:133674026 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.941-10C>A	single nucleotide variant	not provided [RCV001996101]	Chr3:133948710 [GRCh38] Chr3:133667554 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1808G>C (p.Arg603Pro)	single nucleotide variant	not provided [RCV001930956]	Chr3:133935780 [GRCh38] Chr3:133654624 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1718G>T (p.Gly573Val)	single nucleotide variant	not provided [RCV001995724]	Chr3:133935870 [GRCh38] Chr3:133654714 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.940C>T (p.Arg314Trp)	single nucleotide variant	not provided [RCV001905342]	Chr3:133948893 [GRCh38] Chr3:133667737 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1624C>T (p.Arg542Cys)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003642982]\|not provided [RCV001973193]	Chr3:133942606 [GRCh38] Chr3:133661450 [GRCh37] Chr3:3q22.1	pathogenic\|likely pathogenic\|conflicting interpretations of pathogenicity
NM_005630.3(SLCO2A1):c.750C>A (p.Asp250Glu)	single nucleotide variant	not provided [RCV001959389]	Chr3:133951319 [GRCh38] Chr3:133670163 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.281G>A (p.Arg94Gln)	single nucleotide variant	not provided [RCV002047892]	Chr3:133973779 [GRCh38] Chr3:133692623 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.904G>C (p.Ala302Pro)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV004720353]\|not provided [RCV002030634]	Chr3:133948929 [GRCh38] Chr3:133667773 [GRCh37] Chr3:3q22.1	likely benign\|conflicting interpretations of pathogenicity\|uncertain significance
NM_005630.3(SLCO2A1):c.1106G>A (p.Gly369Asp)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003642983]\|not provided [RCV001998798]	Chr3:133947445 [GRCh38] Chr3:133666289 [GRCh37] Chr3:3q22.1	pathogenic\|likely pathogenic
NM_005630.3(SLCO2A1):c.1742T>G (p.Ile581Ser)	single nucleotide variant	not provided [RCV001955397]	Chr3:133935846 [GRCh38] Chr3:133654690 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.402C>A (p.Asn134Lys)	single nucleotide variant	not provided [RCV001870477]	Chr3:133955189 [GRCh38] Chr3:133674033 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1316C>T (p.Pro439Leu)	single nucleotide variant	not provided [RCV002027240]	Chr3:133945240 [GRCh38] Chr3:133664084 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1625+6T>C	single nucleotide variant	not provided [RCV001937572]	Chr3:133942599 [GRCh38] Chr3:133661443 [GRCh37] Chr3:3q22.1	likely pathogenic\|uncertain significance
NM_005630.3(SLCO2A1):c.619T>C (p.Tyr207His)	single nucleotide variant	Inborn genetic diseases [RCV004671565]\|not provided [RCV001993083]	Chr3:133954972 [GRCh38] Chr3:133673816 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1462-9C>T	single nucleotide variant	not provided [RCV002186131]	Chr3:133942777 [GRCh38] Chr3:133661621 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.12G>A (p.Leu4=)	single nucleotide variant	not provided [RCV002071804]	Chr3:134029791 [GRCh38] Chr3:133748635 [GRCh37] Chr3:3q22.2	likely benign
NM_005630.3(SLCO2A1):c.1815-111A>G	single nucleotide variant	not provided [RCV002223634]	Chr3:133934941 [GRCh38] Chr3:133653785 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.847C>T (p.Pro283Ser)	single nucleotide variant	SLCO2A1-related disorder [RCV003903349]\|not provided [RCV002107719]	Chr3:133951222 [GRCh38] Chr3:133670066 [GRCh37] Chr3:3q22.1	benign\|likely benign
NM_005630.3(SLCO2A1):c.1434C>A (p.Asn478Lys)	single nucleotide variant	not provided [RCV002089612]	Chr3:133945122 [GRCh38] Chr3:133663966 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1041C>G (p.Thr347=)	single nucleotide variant	not provided [RCV002092307]	Chr3:133948600 [GRCh38] Chr3:133667444 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.366C>T (p.Ser122=)	single nucleotide variant	not provided [RCV002085446]	Chr3:133973694 [GRCh38] Chr3:133692538 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1551G>A (p.Pro517=)	single nucleotide variant	not provided [RCV002166319]	Chr3:133942679 [GRCh38] Chr3:133661523 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1782C>T (p.Cys594=)	single nucleotide variant	not provided [RCV002151286]	Chr3:133935806 [GRCh38] Chr3:133654650 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1815-14C>T	single nucleotide variant	not provided [RCV002169154]	Chr3:133934844 [GRCh38] Chr3:133653688 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.744G>C (p.Pro248=)	single nucleotide variant	not provided [RCV002080984]	Chr3:133951325 [GRCh38] Chr3:133670169 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.798T>G (p.Ala266=)	single nucleotide variant	not provided [RCV002091682]	Chr3:133951271 [GRCh38] Chr3:133670115 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1371G>C (p.Pro457=)	single nucleotide variant	not provided [RCV002115411]	Chr3:133945185 [GRCh38] Chr3:133664029 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.97-7C>T	single nucleotide variant	not provided [RCV002151681]	Chr3:133979625 [GRCh38] Chr3:133698469 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1815-11C>T	single nucleotide variant	not provided [RCV002205744]	Chr3:133934841 [GRCh38] Chr3:133653685 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.398-7G>A	single nucleotide variant	not provided [RCV002078125]	Chr3:133955200 [GRCh38] Chr3:133674044 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.978A>G (p.Ser326=)	single nucleotide variant	not provided [RCV002149016]	Chr3:133948663 [GRCh38] Chr3:133667507 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.235-18C>T	single nucleotide variant	not provided [RCV002150773]	Chr3:133973843 [GRCh38] Chr3:133692687 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1299A>G (p.Thr433=)	single nucleotide variant	not provided [RCV002078486]	Chr3:133945257 [GRCh38] Chr3:133664101 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.625+8A>G	single nucleotide variant	not provided [RCV002170991]	Chr3:133954958 [GRCh38] Chr3:133673802 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.12G>T (p.Leu4=)	single nucleotide variant	not provided [RCV002185723]	Chr3:134029791 [GRCh38] Chr3:133748635 [GRCh37] Chr3:3q22.2	likely benign
NM_005630.3(SLCO2A1):c.862-16C>A	single nucleotide variant	not provided [RCV002128624]	Chr3:133948987 [GRCh38] Chr3:133667831 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.724+7A>G	single nucleotide variant	not provided [RCV002139291]	Chr3:133953656 [GRCh38] Chr3:133672500 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1814+11A>T	single nucleotide variant	not provided [RCV002219913]	Chr3:133935763 [GRCh38] Chr3:133654607 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1498G>A (p.Ala500Thr)	single nucleotide variant	Inborn genetic diseases [RCV004671642]\|not provided [RCV002083477]	Chr3:133942732 [GRCh38] Chr3:133661576 [GRCh37] Chr3:3q22.1	likely benign\|uncertain significance
NM_005630.3(SLCO2A1):c.663C>T (p.Phe221=)	single nucleotide variant	not provided [RCV002143023]	Chr3:133953724 [GRCh38] Chr3:133672568 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1625+17T>C	single nucleotide variant	not provided [RCV002199538]	Chr3:133942588 [GRCh38] Chr3:133661432 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.1672T>C (p.Leu558=)	single nucleotide variant	not provided [RCV002177733]	Chr3:133938447 [GRCh38] Chr3:133657291 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1814+7G>A	single nucleotide variant	not provided [RCV002217126]	Chr3:133935767 [GRCh38] Chr3:133654611 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1296-16C>T	single nucleotide variant	not provided [RCV002098920]	Chr3:133945276 [GRCh38] Chr3:133664120 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.398-17A>G	single nucleotide variant	not provided [RCV002158881]	Chr3:133955210 [GRCh38] Chr3:133674054 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.210G>A (p.Ser70=)	single nucleotide variant	not provided [RCV002217650]	Chr3:133979505 [GRCh38] Chr3:133698349 [GRCh37] Chr3:3q22.1	benign
NC_000003.11:g.(?_133661429)_(133698482_?)dup	duplication	not provided [RCV003116405]	Chr3:133661429..133698482 [GRCh37] Chr3:3q22.1	likely pathogenic
NC_000003.11:g.(?_133653557)_(133674057_?)dup	duplication	not provided [RCV003116406]	Chr3:133653557..133674057 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1509G>T (p.Lys503Asn)	single nucleotide variant	Inborn genetic diseases [RCV004963545]\|not provided [RCV003112480]	Chr3:133942721 [GRCh38] Chr3:133661565 [GRCh37] Chr3:3q22.1	conflicting interpretations of pathogenicity\|uncertain significance
NM_005630.3(SLCO2A1):c.1282G>T (p.Val428Phe)	single nucleotide variant	not provided [RCV003118538]	Chr3:133947269 [GRCh38] Chr3:133666113 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1371G>A (p.Pro457=)	single nucleotide variant	not provided [RCV003120010]	Chr3:133945185 [GRCh38] Chr3:133664029 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1381G>C (p.Asp461His)	single nucleotide variant	Inborn genetic diseases [RCV004683903]	Chr3:133945175 [GRCh38] Chr3:133664019 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.389C>T (p.Ala130Val)	single nucleotide variant	Inborn genetic diseases [RCV004683904]	Chr3:133973671 [GRCh38] Chr3:133692515 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1162A>G (p.Lys388Glu)	single nucleotide variant	not provided [RCV002303813]	Chr3:133947389 [GRCh38] Chr3:133666233 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1873A>T (p.Ser625Cys)	single nucleotide variant	not provided [RCV002299887]	Chr3:133934772 [GRCh38] Chr3:133653616 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1382A>G (p.Asp461Gly)	single nucleotide variant	not provided [RCV002296026]	Chr3:133945174 [GRCh38] Chr3:133664018 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1745G>A (p.Arg582Gln)	single nucleotide variant	not provided [RCV002903382]	Chr3:133935843 [GRCh38] Chr3:133654687 [GRCh37] Chr3:3q22.1	likely benign\|conflicting interpretations of pathogenicity\|uncertain significance
NM_005630.3(SLCO2A1):c.1768del (p.Arg590fs)	deletion	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003776900]\|not provided [RCV002774969]	Chr3:133935820 [GRCh38] Chr3:133654664 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.651T>C (p.Phe217=)	single nucleotide variant	not provided [RCV002615470]	Chr3:133953736 [GRCh38] Chr3:133672580 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.398-14C>T	single nucleotide variant	not provided [RCV002681555]	Chr3:133955207 [GRCh38] Chr3:133674051 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.964C>T (p.Leu322Phe)	single nucleotide variant	Inborn genetic diseases [RCV002865202]	Chr3:133948677 [GRCh38] Chr3:133667521 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1476C>T (p.Cys492=)	single nucleotide variant	not provided [RCV002838364]	Chr3:133942754 [GRCh38] Chr3:133661598 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1205C>T (p.Thr402Ile)	single nucleotide variant	Inborn genetic diseases [RCV002732396]	Chr3:133947346 [GRCh38] Chr3:133666190 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.56G>C (p.Arg19Pro)	single nucleotide variant	Inborn genetic diseases [RCV002689690]	Chr3:134029747 [GRCh38] Chr3:133748591 [GRCh37] Chr3:3q22.2	uncertain significance
NM_005630.3(SLCO2A1):c.878C>T (p.Ala293Val)	single nucleotide variant	Inborn genetic diseases [RCV002777560]	Chr3:133948955 [GRCh38] Chr3:133667799 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.356A>G (p.His119Arg)	single nucleotide variant	not provided [RCV002780942]	Chr3:133973704 [GRCh38] Chr3:133692548 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1615A>G (p.Met539Val)	single nucleotide variant	not provided [RCV002948842]	Chr3:133942615 [GRCh38] Chr3:133661459 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.63C>T (p.Gly21=)	single nucleotide variant	not provided [RCV002570008]	Chr3:134029740 [GRCh38] Chr3:133748584 [GRCh37] Chr3:3q22.2	likely benign
NM_005630.3(SLCO2A1):c.1345T>C (p.Ser449Pro)	single nucleotide variant	not provided [RCV003053715]	Chr3:133945211 [GRCh38] Chr3:133664055 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1728T>A (p.Ile576=)	single nucleotide variant	not provided [RCV002824727]	Chr3:133935860 [GRCh38] Chr3:133654704 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1626-17C>G	single nucleotide variant	not provided [RCV002570902]	Chr3:133938510 [GRCh38] Chr3:133657354 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1845G>A (p.Ala615=)	single nucleotide variant	not provided [RCV002592338]	Chr3:133934800 [GRCh38] Chr3:133653644 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1799A>T (p.Asp600Val)	single nucleotide variant	not provided [RCV002694893]	Chr3:133935789 [GRCh38] Chr3:133654633 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.941-14C>T	single nucleotide variant	not provided [RCV002569728]	Chr3:133948714 [GRCh38] Chr3:133667558 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.1550C>T (p.Pro517Leu)	single nucleotide variant	Inborn genetic diseases [RCV002980607]\|not provided [RCV003108206]	Chr3:133942680 [GRCh38] Chr3:133661524 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.817T>C (p.Phe273Leu)	single nucleotide variant	not provided [RCV002619512]	Chr3:133951252 [GRCh38] Chr3:133670096 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.517A>C (p.Met173Leu)	single nucleotide variant	not provided [RCV002706701]	Chr3:133955074 [GRCh38] Chr3:133673918 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.456C>T (p.Pro152=)	single nucleotide variant	not provided [RCV003042621]	Chr3:133955135 [GRCh38] Chr3:133673979 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1851C>G (p.Gly617=)	single nucleotide variant	not provided [RCV003056420]	Chr3:133934794 [GRCh38] Chr3:133653638 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.184C>T (p.Arg62Cys)	single nucleotide variant	not provided [RCV002595455]	Chr3:133979531 [GRCh38] Chr3:133698375 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.23G>A (p.Gly8Asp)	single nucleotide variant	not provided [RCV002957369]	Chr3:134029780 [GRCh38] Chr3:133748624 [GRCh37] Chr3:3q22.2	uncertain significance
NM_005630.3(SLCO2A1):c.1537C>G (p.His513Asp)	single nucleotide variant	Inborn genetic diseases [RCV003269217]\|not provided [RCV002625991]	Chr3:133942693 [GRCh38] Chr3:133661537 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.602C>T (p.Pro201Leu)	single nucleotide variant	not provided [RCV002593639]	Chr3:133954989 [GRCh38] Chr3:133673833 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.398-8C>T	single nucleotide variant	not provided [RCV002573747]	Chr3:133955201 [GRCh38] Chr3:133674045 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1417G>A (p.Gly473Ser)	single nucleotide variant	not provided [RCV002573789]	Chr3:133945139 [GRCh38] Chr3:133663983 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1489G>A (p.Gly497Arg)	single nucleotide variant	not provided [RCV002593564]	Chr3:133942741 [GRCh38] Chr3:133661585 [GRCh37] Chr3:3q22.1	likely benign\|uncertain significance
NM_005630.3(SLCO2A1):c.570T>G (p.Phe190Leu)	single nucleotide variant	not provided [RCV002982788]	Chr3:133955021 [GRCh38] Chr3:133673865 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1373T>C (p.Val458Ala)	single nucleotide variant	not provided [RCV002928462]	Chr3:133945183 [GRCh38] Chr3:133664027 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.96+7G>T	single nucleotide variant	not provided [RCV002894465]	Chr3:134029700 [GRCh38] Chr3:133748544 [GRCh37] Chr3:3q22.2	likely benign
NM_005630.3(SLCO2A1):c.1573G>A (p.Val525Met)	single nucleotide variant	not provided [RCV002623513]	Chr3:133942657 [GRCh38] Chr3:133661501 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1021G>A (p.Val341Ile)	single nucleotide variant	not provided [RCV003085418]	Chr3:133948620 [GRCh38] Chr3:133667464 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.941-13G>A	single nucleotide variant	not provided [RCV002786627]	Chr3:133948713 [GRCh38] Chr3:133667557 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.823T>A (p.Phe275Ile)	single nucleotide variant	Inborn genetic diseases [RCV003250526]\|not provided [RCV002596792]	Chr3:133951246 [GRCh38] Chr3:133670090 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.943T>C (p.Phe315Leu)	single nucleotide variant	not provided [RCV002811348]	Chr3:133948698 [GRCh38] Chr3:133667542 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.896T>C (p.Leu299Ser)	single nucleotide variant	not provided [RCV003049035]	Chr3:133948937 [GRCh38] Chr3:133667781 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1488C>T (p.Thr496=)	single nucleotide variant	not provided [RCV002602900]	Chr3:133942742 [GRCh38] Chr3:133661586 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1291C>T (p.Pro431Ser)	single nucleotide variant	not provided [RCV003091603]	Chr3:133947260 [GRCh38] Chr3:133666104 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.626-15T>A	single nucleotide variant	not provided [RCV002580566]	Chr3:133953776 [GRCh38] Chr3:133672620 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.379T>C (p.Tyr127His)	single nucleotide variant	Inborn genetic diseases [RCV002668491]	Chr3:133973681 [GRCh38] Chr3:133692525 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.473C>A (p.Thr158Asn)	single nucleotide variant	Inborn genetic diseases [RCV002855120]	Chr3:133955118 [GRCh38] Chr3:133673962 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1542C>T (p.Phe514=)	single nucleotide variant	not provided [RCV002746390]	Chr3:133942688 [GRCh38] Chr3:133661532 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.538G>T (p.Ala180Ser)	single nucleotide variant	Inborn genetic diseases [RCV002920780]	Chr3:133955053 [GRCh38] Chr3:133673897 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1771C>T (p.Arg591Ter)	single nucleotide variant	not provided [RCV002651747]	Chr3:133935817 [GRCh38] Chr3:133654661 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.743C>T (p.Pro248Leu)	single nucleotide variant	Inborn genetic diseases [RCV003308376]\|not provided [RCV002961932]	Chr3:133951326 [GRCh38] Chr3:133670170 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.842C>T (p.Ala281Val)	single nucleotide variant	not provided [RCV002631921]	Chr3:133951227 [GRCh38] Chr3:133670071 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.226T>C (p.Leu76=)	single nucleotide variant	not provided [RCV003091459]	Chr3:133979489 [GRCh38] Chr3:133698333 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1815-17CCT[2]	microsatellite	not provided [RCV002676056]	Chr3:133934839..133934841 [GRCh38] Chr3:133653683..133653685 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.234+19T>C	single nucleotide variant	not provided [RCV002899527]	Chr3:133979462 [GRCh38] Chr3:133698306 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.949T>C (p.Cys317Arg)	single nucleotide variant	Inborn genetic diseases [RCV004966515]	Chr3:133948692 [GRCh38] Chr3:133667536 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.53G>T (p.Ser18Ile)	single nucleotide variant	Inborn genetic diseases [RCV004966518]	Chr3:134029750 [GRCh38] Chr3:133748594 [GRCh37] Chr3:3q22.2	uncertain significance
NM_005630.3(SLCO2A1):c.1060G>A (p.Glu354Lys)	single nucleotide variant	Inborn genetic diseases [RCV004966516]	Chr3:133948581 [GRCh38] Chr3:133667425 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.97-3C>T	single nucleotide variant	not provided [RCV002942720]	Chr3:133979621 [GRCh38] Chr3:133698465 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.159G>A (p.Lys53=)	single nucleotide variant	not provided [RCV002726152]	Chr3:133979556 [GRCh38] Chr3:133698400 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.392G>A (p.Ser131Asn)	single nucleotide variant	not provided [RCV002609856]	Chr3:133973668 [GRCh38] Chr3:133692512 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1815-15T>G	single nucleotide variant	not provided [RCV002589105]	Chr3:133934845 [GRCh38] Chr3:133653689 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.626-17C>T	single nucleotide variant	not provided [RCV003852667]	Chr3:133953778 [GRCh38] Chr3:133672622 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.289C>T (p.Arg97Cys)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003229536]	Chr3:133973771 [GRCh38] Chr3:133692615 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.234+5G>A	single nucleotide variant	not provided [RCV003136860]	Chr3:133979476 [GRCh38] Chr3:133698320 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1772G>A (p.Arg591Gln)	single nucleotide variant	Inborn genetic diseases [RCV003176074]	Chr3:133935816 [GRCh38] Chr3:133654660 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.659C>T (p.Ala220Val)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003447863]	Chr3:133953728 [GRCh38] Chr3:133672572 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.83_96+8del	deletion	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003389097]	Chr3:134029699..134029720 [GRCh38] Chr3:133748543..133748564 [GRCh37] Chr3:3q22.2	likely pathogenic
NM_005630.3(SLCO2A1):c.663del (p.Phe221fs)	deletion	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003447855]	Chr3:133953724 [GRCh38] Chr3:133672568 [GRCh37] Chr3:3q22.1	likely pathogenic
NM_005630.3(SLCO2A1):c.1295+20G>C	single nucleotide variant	not provided [RCV003579292]	Chr3:133947236 [GRCh38] Chr3:133666080 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.421G>T (p.Glu141Ter)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003643500]	Chr3:133955170 [GRCh38] Chr3:133674014 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.1668G>C (p.Gln556His)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003643507]	Chr3:133938451 [GRCh38] Chr3:133657295 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.763G>A (p.Gly255Arg)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003643508]	Chr3:133951306 [GRCh38] Chr3:133670150 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.1372G>T (p.Val458Phe)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003643511]	Chr3:133945184 [GRCh38] Chr3:133664028 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.625+11G>A	single nucleotide variant	not provided [RCV003880164]	Chr3:133954955 [GRCh38] Chr3:133673799 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.234+8G>A	single nucleotide variant	not provided [RCV003578615]	Chr3:133979473 [GRCh38] Chr3:133698317 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1296-20G>A	single nucleotide variant	not provided [RCV003849105]	Chr3:133945280 [GRCh38] Chr3:133664124 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.626-5del	deletion	not provided [RCV003694348]	Chr3:133953766 [GRCh38] Chr3:133672610 [GRCh37] Chr3:3q22.1	benign
NM_005630.3(SLCO2A1):c.1497dup (p.Ala500fs)	duplication	not provided [RCV003545150]	Chr3:133942732..133942733 [GRCh38] Chr3:133661576..133661577 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.234+17G>T	single nucleotide variant	not provided [RCV003877292]	Chr3:133979464 [GRCh38] Chr3:133698308 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1106-1G>A	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003643501]	Chr3:133947446 [GRCh38] Chr3:133666290 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.794del (p.Ser264_Ser265insTer)	deletion	not provided [RCV003876329]	Chr3:133951275 [GRCh38] Chr3:133670119 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.336C>T (p.Ala112=)	single nucleotide variant	not provided [RCV003579095]	Chr3:133973724 [GRCh38] Chr3:133692568 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.625+10C>T	single nucleotide variant	not provided [RCV003828922]	Chr3:133954956 [GRCh38] Chr3:133673800 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.178G>A (p.Glu60Lys)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003643502]	Chr3:133979537 [GRCh38] Chr3:133698381 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.759G>A (p.Trp253Ter)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003643503]	Chr3:133951310 [GRCh38] Chr3:133670154 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.855del (p.Ala286fs)	deletion	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003643509]	Chr3:133951214 [GRCh38] Chr3:133670058 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.440G>A (p.Trp147Ter)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003643504]	Chr3:133955151 [GRCh38] Chr3:133673995 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.1095C>A (p.Asn365Lys)	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003643505]	Chr3:133948546 [GRCh38] Chr3:133667390 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.1461+1G>C	single nucleotide variant	Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 [RCV003643510]	Chr3:133945094 [GRCh38] Chr3:133663938 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.1767G>A (p.Gly589=)	single nucleotide variant	not provided [RCV003828187]	Chr3:133935821 [GRCh38] Chr3:133654665 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.120C>T (p.Leu40=)	single nucleotide variant	not provided [RCV003852355]	Chr3:133979595 [GRCh38] Chr3:133698439 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.900G>A (p.Glu300=)	single nucleotide variant	not provided [RCV003698370]	Chr3:133948933 [GRCh38] Chr3:133667777 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.546C>T (p.Ile182=)	single nucleotide variant	not provided [RCV003726425]	Chr3:133955045 [GRCh38] Chr3:133673889 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1917G>A (p.Ala639=)	single nucleotide variant	not provided [RCV003548793]	Chr3:133934728 [GRCh38] Chr3:133653572 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1625+8G>C	single nucleotide variant	not provided [RCV003855785]	Chr3:133942597 [GRCh38] Chr3:133661441 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1827G>A (p.Leu609=)	single nucleotide variant	not provided [RCV003851454]	Chr3:133934818 [GRCh38] Chr3:133653662 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.582T>C (p.Tyr194=)	single nucleotide variant	not provided [RCV003665654]	Chr3:133955009 [GRCh38] Chr3:133673853 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1347G>A (p.Ser449=)	single nucleotide variant	not provided [RCV003815827]	Chr3:133945209 [GRCh38] Chr3:133664053 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.861+13G>C	single nucleotide variant	not provided [RCV003680026]	Chr3:133951195 [GRCh38] Chr3:133670039 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.645T>G (p.Ser215=)	single nucleotide variant	not provided [RCV003708048]	Chr3:133953742 [GRCh38] Chr3:133672586 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.147C>T (p.Ser49=)	single nucleotide variant	not provided [RCV003844127]	Chr3:133979568 [GRCh38] Chr3:133698412 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.918C>T (p.Gly306=)	single nucleotide variant	not provided [RCV003709983]	Chr3:133948915 [GRCh38] Chr3:133667759 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.139C>G (p.Leu47Val)	single nucleotide variant	not provided [RCV003568186]	Chr3:133979576 [GRCh38] Chr3:133698420 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.626-4C>T	single nucleotide variant	not provided [RCV003847407]	Chr3:133953765 [GRCh38] Chr3:133672609 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1296-17dup	duplication	not provided [RCV003819178]	Chr3:133945276..133945277 [GRCh38] Chr3:133664120..133664121 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1497C>T (p.Ser499=)	single nucleotide variant	not provided [RCV003553250]	Chr3:133942733 [GRCh38] Chr3:133661577 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.862-4T>C	single nucleotide variant	not provided [RCV003720439]	Chr3:133948975 [GRCh38] Chr3:133667819 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.724+8T>C	single nucleotide variant	not provided [RCV003857769]	Chr3:133953655 [GRCh38] Chr3:133672499 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.732T>C (p.Val244=)	single nucleotide variant	not provided [RCV003681930]	Chr3:133951337 [GRCh38] Chr3:133670181 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1572C>T (p.Phe524=)	single nucleotide variant	not provided [RCV003728136]	Chr3:133942658 [GRCh38] Chr3:133661502 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1899G>A (p.Glu633=)	single nucleotide variant	not provided [RCV003554100]	Chr3:133934746 [GRCh38] Chr3:133653590 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.873C>T (p.Ala291=)	single nucleotide variant	not provided [RCV003732396]	Chr3:133948960 [GRCh38] Chr3:133667804 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.102T>C (p.Phe34=)	single nucleotide variant	not provided [RCV003678438]	Chr3:133979613 [GRCh38] Chr3:133698457 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1278C>T (p.Ala426=)	single nucleotide variant	SLCO2A1-related disorder [RCV003954371]	Chr3:133947273 [GRCh38] Chr3:133666117 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.126G>A (p.Gln42=)	single nucleotide variant	SLCO2A1-related disorder [RCV003911936]	Chr3:133979589 [GRCh38] Chr3:133698433 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.209_210insA (p.Leu72fs)	insertion	Pachydermoperiostosis syndrome [RCV003994633]	Chr3:133979505..133979506 [GRCh38] Chr3:133698349..133698350 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.252C>T (p.Leu84=)	single nucleotide variant	SLCO2A1-related disorder [RCV003961429]	Chr3:133973808 [GRCh38] Chr3:133692652 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.388G>T (p.Ala130Ser)	single nucleotide variant	Inborn genetic diseases [RCV004457156]	Chr3:133973672 [GRCh38] Chr3:133692516 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1153A>C (p.Ile385Leu)	single nucleotide variant	Inborn genetic diseases [RCV004457152]	Chr3:133947398 [GRCh38] Chr3:133666242 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1297A>G (p.Thr433Ala)	single nucleotide variant	Inborn genetic diseases [RCV004457153]	Chr3:133945259 [GRCh38] Chr3:133664103 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.28T>C (p.Ser10Pro)	single nucleotide variant	Inborn genetic diseases [RCV004457155]	Chr3:134029775 [GRCh38] Chr3:133748619 [GRCh37] Chr3:3q22.2	likely benign
NM_005630.3(SLCO2A1):c.1534G>C (p.Ala512Pro)	single nucleotide variant	Inborn genetic diseases [RCV004457154]	Chr3:133942696 [GRCh38] Chr3:133661540 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.613C>T (p.Pro205Ser)	single nucleotide variant	Inborn genetic diseases [RCV004667412]	Chr3:133954978 [GRCh38] Chr3:133673822 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.124C>G (p.Gln42Glu)	single nucleotide variant	Inborn genetic diseases [RCV004667413]	Chr3:133979591 [GRCh38] Chr3:133698435 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1133T>C (p.Leu378Ser)	single nucleotide variant	Inborn genetic diseases [RCV004667411]	Chr3:133947418 [GRCh38] Chr3:133666262 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.656C>T (p.Pro219Leu)	single nucleotide variant	not specified [RCV004597518]	Chr3:133953731 [GRCh38] Chr3:133672575 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1099C>G (p.Leu367Val)	single nucleotide variant	Inborn genetic diseases [RCV004667410]	Chr3:133948542 [GRCh38] Chr3:133667386 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.505A>C (p.Met169Leu)	single nucleotide variant	Inborn genetic diseases [RCV004966514]	Chr3:133955086 [GRCh38] Chr3:133673930 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.118C>G (p.Leu40Val)	single nucleotide variant	Inborn genetic diseases [RCV004966519]	Chr3:133979597 [GRCh38] Chr3:133698441 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1430T>A (p.Ile477Asn)	single nucleotide variant	Inborn genetic diseases [RCV004966520]	Chr3:133945126 [GRCh38] Chr3:133663970 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.320T>G (p.Phe107Cys)	single nucleotide variant	Inborn genetic diseases [RCV004966517]	Chr3:133973740 [GRCh38] Chr3:133692584 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.398G>A (p.Gly133Glu)	single nucleotide variant	not provided [RCV004773971]	Chr3:133955193 [GRCh38] Chr3:133674037 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1272T>A (p.Thr424=)	single nucleotide variant	not provided [RCV005140426]	Chr3:133947279 [GRCh38] Chr3:133666123 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.755G>A (p.Arg252Gln)	single nucleotide variant	not provided [RCV005106774]	Chr3:133951314 [GRCh38] Chr3:133670158 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1464C>T (p.Ile488=)	single nucleotide variant	not provided [RCV005110924]	Chr3:133942766 [GRCh38] Chr3:133661610 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1518G>A (p.Ser506=)	single nucleotide variant	not provided [RCV005060634]	Chr3:133942712 [GRCh38] Chr3:133661556 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1621C>T (p.Leu541=)	single nucleotide variant	not provided [RCV005148008]	Chr3:133942609 [GRCh38] Chr3:133661453 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1625+13C>A	single nucleotide variant	not provided [RCV005079675]	Chr3:133942592 [GRCh38] Chr3:133661436 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.408C>T (p.Ser136=)	single nucleotide variant	not provided [RCV005078588]	Chr3:133955183 [GRCh38] Chr3:133674027 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1183C>T (p.Gln395Ter)	single nucleotide variant	not provided [RCV005167594]	Chr3:133947368 [GRCh38] Chr3:133666212 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.1022del (p.Val341fs)	deletion	not provided [RCV005169606]	Chr3:133948619 [GRCh38] Chr3:133667463 [GRCh37] Chr3:3q22.1	pathogenic
NM_005630.3(SLCO2A1):c.1207A>G (p.Thr403Ala)	single nucleotide variant	not provided [RCV005073886]	Chr3:133947344 [GRCh38] Chr3:133666188 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.1701A>C (p.Pro567=)	single nucleotide variant	not provided [RCV005197452]	Chr3:133935887 [GRCh38] Chr3:133654731 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.369G>A (p.Glu123=)	single nucleotide variant	not provided [RCV005191112]	Chr3:133973691 [GRCh38] Chr3:133692535 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1861C>T (p.Leu621Phe)	single nucleotide variant	not provided [RCV005184157]	Chr3:133934784 [GRCh38] Chr3:133653628 [GRCh37] Chr3:3q22.1	uncertain significance
NM_005630.3(SLCO2A1):c.948A>T (p.Pro316=)	single nucleotide variant	not provided [RCV005169343]	Chr3:133948693 [GRCh38] Chr3:133667537 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.941-14C>A	single nucleotide variant	not provided [RCV005178084]	Chr3:133948714 [GRCh38] Chr3:133667558 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.1105+14G>T	single nucleotide variant	not provided [RCV005157125]	Chr3:133948522 [GRCh38] Chr3:133667366 [GRCh37] Chr3:3q22.1	likely benign
NM_005630.3(SLCO2A1):c.725-13G>A	single nucleotide variant	not provided [RCV005069431]	Chr3:133951357 [GRCh38] Chr3:133670201 [GRCh37] Chr3:3q22.1	likely benign

Predicted Target Of

	Summary Value
Count of predictions:	3113
Count of miRNA genes:	1097
Interacting mature miRNAs:	1376
Transcripts:	ENST00000310926, ENST00000462770, ENST00000464676, ENST00000477061, ENST00000478651, ENST00000478662, ENST00000481359, ENST00000493729
Prediction methods:	Microtar, Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597159858	GWAS1255932_H	lipid measurement QTL GWAS1255932 (human)		0.000003	lipid measurement	blood lipid measurement (CMO:0000050)	3	133972321	133972322	Human
597309340	GWAS1405414_H	vaginal microbiome measurement QTL GWAS1405414 (human)		0.000004	vaginal microbiome measurement		3	133947365	133947366	Human
597162652	GWAS1258726_H	lipid measurement QTL GWAS1258726 (human)		0.000001	lipid measurement	blood lipid measurement (CMO:0000050)	3	133972321	133972322	Human
597036550	GWAS1132624_H	colorectal cancer, colorectal adenoma QTL GWAS1132624 (human)		4e-09	colorectal cancer, colorectal adenoma		3	133982275	133982276	Human
597605807	GWAS1662667_H	Abnormality of the immune system QTL GWAS1662667 (human)		4e-13	Abnormality of the immune system		3	133940121	133940122	Human
597151971	GWAS1248045_H	colorectal cancer QTL GWAS1248045 (human)		1e-09	colorectal cancer		3	134018138	134018139	Human
597163203	GWAS1259277_H	colorectal cancer QTL GWAS1259277 (human)		3e-10	colorectal cancer		3	134026952	134026953	Human
597294670	GWAS1390744_H	revision of total joint arthroplasty QTL GWAS1390744 (human)		0.000001	revision of total joint arthroplasty		3	133956309	133956310	Human
597324653	GWAS1420727_H	colorectal cancer QTL GWAS1420727 (human)		5e-14	colorectal cancer		3	133982275	133982276	Human
597309570	GWAS1405644_H	vaginal microbiome measurement QTL GWAS1405644 (human)		0.000007	vaginal microbiome measurement		3	133951381	133951382	Human
597108943	GWAS1205017_H	response to radiation, Hematuria QTL GWAS1205017 (human)		0.0000004	response to radiation, Hematuria		3	133982979	133982980	Human
597309569	GWAS1405643_H	vaginal microbiome measurement QTL GWAS1405643 (human)		0.000004	vaginal microbiome measurement		3	133951229	133951230	Human
596965871	GWAS1085390_H	colorectal cancer QTL GWAS1085390 (human)		2e-09	colorectal cancer		3	133988157	133988158	Human
596965865	GWAS1085384_H	colorectal cancer QTL GWAS1085384 (human)		1e-09	colorectal cancer		3	134018138	134018139	Human
597151976	GWAS1248050_H	colorectal cancer QTL GWAS1248050 (human)		2e-09	colorectal cancer		3	133988157	133988158	Human

SHGC-77366

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	133,651,588 - 133,651,688	UniSTS	GRCh37
Build 36	3	135,134,278 - 135,134,378	RGD	NCBI36
Celera	3	132,077,443 - 132,077,543	RGD
Cytogenetic Map	3	q21	UniSTS
HuRef	3	131,029,718 - 131,029,818	UniSTS
TNG Radiation Hybrid Map	3	77469.0	UniSTS
GeneMap99-GB4 RH Map	3	473.72	UniSTS
Whitehead-RH Map	3	615.8	UniSTS
NCBI RH Map	3	1189.4	UniSTS

SLC21A2_824

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	133,651,537 - 133,652,376	UniSTS	GRCh37
Build 36	3	135,134,227 - 135,135,066	RGD	NCBI36
Celera	3	132,077,392 - 132,078,231	RGD
HuRef	3	131,029,667 - 131,030,506	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	nervous system	renal system	reproductive system	respiratory system	sensory system
1204	2215	2786	2196	4487	1420	1702	388	1164	226	1968	5759	5581	3543	511	1395	1231	162


RefSeq Transcripts	NG_031964	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_005630	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AB201109	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AB201110	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AB201111	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC080128	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC117475	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AH006899	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK303550	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK309561	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC041140	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC051347	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BU783445	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471052	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068275	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DA592947	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	U70867	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000310926 ⟹ ENSP00000311291

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	133,932,701 - 134,029,925 (-)	Ensembl

Ensembl Acc Id:

ENST00000462770

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	133,942,312 - 134,029,925 (-)	Ensembl

Ensembl Acc Id:

ENST00000464676

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	133,950,952 - 134,029,925 (-)	Ensembl

Ensembl Acc Id:

ENST00000477061

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	133,948,654 - 133,949,216 (-)	Ensembl

Ensembl Acc Id:

ENST00000478651

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	133,955,343 - 134,029,925 (-)	Ensembl

Ensembl Acc Id:

ENST00000478662

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	133,979,547 - 134,052,184 (-)	Ensembl

Ensembl Acc Id:

ENST00000481359 ⟹ ENSP00000420028

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	133,934,639 - 134,029,923 (-)	Ensembl

Ensembl Acc Id:

ENST00000493729 ⟹ ENSP00000418893

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	133,934,611 - 134,029,914 (-)	Ensembl

RefSeq Acc Id:

NM_005630 ⟹ NP_005621

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	133,932,701 - 134,029,925 (-)	NCBI
GRCh37	3	133,651,540 - 133,748,920 (-)	ENTREZGENE
Build 36	3	135,134,230 - 135,231,418 (-)	NCBI Archive
HuRef	3	131,029,670 - 131,126,922 (-)	ENTREZGENE
CHM1_1	3	133,615,353 - 133,712,732 (-)	NCBI
T2T-CHM13v2.0	3	136,677,860 - 136,775,063 (-)	NCBI

Sequence:

show sequence

AGTCTCCGCTCCGCGAATCTCCTCCGGCCACTGCCGCCGCGGTCGCCTCTCACCCGCCCGGCCGCTCCAGCCCGAGGCGCCCCGACCCCGCGCCACTCCGCGCCCGGCCAGCCGCCCGCAGCCATGGG
GCTCCTGCCCAAGCTCGGCGCGTCCCAGGGCAGCGACACCTCTACTAGCCGAGCCGGCCGCTGTGCCCGCTCGGTCTTCGGCAACATTAAGGTGTTTGTGCTCTGCCAAGGCCTCCTGCAGCTCTGCC
AACTCCTGTACAGCGCCTACTTCAAGAGCAGCCTCACCACCATTGAGAAGCGCTTTGGGCTCTCCAGTTCTTCATCGGGTCTCATTTCCAGCTTGAATGAGATCAGCAATGCCATCCTCATCATCTTT
GTCAGCTACTTTGGCAGCCGGGTGCACCGTCCACGTCTGATTGGCATCGGAGGTCTCTTCCTGGCTGCAGGTGCCTTCATCCTCACCCTCCCACACTTCCTCTCCGAGCCCTACCAGTACACCTTGGC
CAGCACTGGGAACAACAGCCGCTTGCAGGCCGAGCTCTGCCAGAAGCATTGGCAGGACCTGCCTCCCAGTAAGTGCCACAGCACCACCCAGAACCCCCAGAAGGAGACCAGCAGCATGTGGGGCCTGA
TGGTGGTTGCCCAGCTGCTGGCTGGCATCGGGACAGTGCCTATTCAGCCATTTGGGATCTCCTATGTGGATGACTTCTCAGAGCCCAGCAACTCGCCCCTGTACATCTCCATCTTATTTGCCATCTCT
GTATTTGGACCGGCTTTCGGGTACCTGCTGGGCTCTGTCATGCTGCAGATCTTTGTGGACTATGGCAGGGTCAACACAGCTGCAGTTAACTTGGTCCCGGGTGACCCCCGATGGATTGGAGCCTGGTG
GCTAGGCCTGCTCATTTCTTCAGCTTTATTGGTTCTCACCTCTTTCCCCTTTTTTTTCTTCCCTCGAGCAATGCCCATAGGAGCAAAGAGGGCTCCTGCCACAGCAGATGAAGCAAGGAAGTTGGAGG
AGGCCAAGTCAAGAGGCTCCCTGGTGGATTTCATTAAACGGTTTCCATGCATCTTTCTGAGGCTCCTGATGAACTCACTCTTCGTCCTGGTGGTCCTGGCCCAGTGCACCTTCTCCTCCGTCATTGCT
GGCCTCTCCACCTTCCTCAACAAGTTCCTGGAGAAGCAGTATGGCACCTCAGCAGCCTATGCCAACTTCCTCATTGGTGCTGTGAACCTCCCTGCTGCAGCCTTGGGGATGCTGTTTGGAGGAATCCT
CATGAAGCGCTTTGTTTTCTCTCTACAAGCCATTCCCCGCATAGCTACCACCATCATCACCATCTCCATGATCCTTTGTGTTCCTTTGTTCTTCATGGGATGCTCCACCCCAACTGTGGCCGAAGTCT
ACCCCCCTAGCACATCAAGTTCTATACATCCGCAGTCTCCTGCCTGCCGCAGGGACTGCTCGTGCCCAGATTCTATCTTCCACCCGGTCTGTGGAGACAATGGAATCGAGTACCTCTCCCCTTGCCAT
GCCGGCTGCAGCAACATCAACATGAGCTCTGCAACCTCCAAGCAACTGATCTATTTGAACTGCAGCTGTGTGACCGGGGGATCCGCTTCAGCAAAGACAGGATCGTGCCCTGTCCCCTGTGCCCACTT
CCTGCTCCCGGCCATCTTCCTCATCTCCTTCGTGTCCCTGATAGCCTGCATCTCCCACAACCCCCTCTACATGATGGTTCTGCGTGTGGTGAACCAGGAGGAAAAGTCATTTGCCATCGGGGTGCAGT
TCTTGTTGATGCGCTTGCTGGCCTGGCTGCCATCTCCAGCCCTCTATGGCCTCACCATTGACCACTCCTGCATCCGGTGGAACTCGCTGTGCTTGGGGAGGCGAGGGGCCTGCGCCTACTATGACAAC
GATGCTCTCCGAGACAGGTACCTGGGCCTGCAGATGGGCTACAAGGCGCTGGGCATGCTGCTGCTTTGCTTCATCAGCTGGAGGGTGAAGAAGAACAAGGAGTACAACGTGCAGAAGGCGGCAGGCCT
CATCTGACCCCACCCTGGGCCACTGCCCTGCTCCAGAGAGTGGACCTTGACTCTTCCACACCTGCCTATACTCACTAATGTTAACACGTCATTTCCTTTTTGTATTTTTAAACAAGAAAGAAAACCCC
AGTCCTCATTTGCCTTCCCTACCTCTTCCTCCCAGAGTCCTCCCCACAGTTCCTAAGGGCCACTGTGTACCCGGGCTGTGTGGGCCAGAACTGGGGGGCTGAGTCTTCCCTGGCCCCTTGGAAGAGGC
CCCCAGATGCCCAGGCTCACTTCAGTGTTGAGTCCTCCATTGAGGATGCCCACTGAGGCAGCCAGGCCCCTCACCAGCCCTGGGGGGAATCCTAAACAGAGAGAGAAAAAGGGTATCTGCCCTTCTTG
CCAGGCAGCTCCACTCTCCCGCTGACTGCCCACACCCTGCAGAGTGGCAGGGGTGAAAGGAAGAAGGAAGTGGCTGAGTTATTAATAGCCAGAGCCACTGGGAGACTGGGGAGACTGGCTGTAACCCC
CTTCACACCTGGGTTTGGCATCAGCACAGACTACGGGAGGGGCTGGCTCCCTCCCCCTCAGACCCTCACTTCCTGTACCTAGAGGCCATTCTGGATGCTGCCATGTTGGGAAGTACAGTCTCTGCCCA
TTACCTGCATGCAGGCACCAGAGCAGGGACTGAGAAACCCCAAGGATGGGTCATCTAAGTGCTGTCCATATGAACCCTGGACTTTCTGTCCTTAGATCCTCACATGTTATCCCTGTCTTTCTGGGGTA
CGTTTCAAACTGAGGAAGCTACAACACAGTGAAGACCCAAGGAAGGCCTATGAAAAGGTCCTGATGCCCAACCTCCCACCCCTTCAATGTGGGGACGAGACCCCCTCATCTCAGAGTAATGGGAAGAA
CCTCCCACATCTCCCTGGCAGCAGATGAGGTGGCTTCACATGCACTTCCCTGTCTGGACTTCAGCCCGTATTCCGAGGAGTAGAGAGGCAGAAGAGATGTCAGCAAAGCAAGTGATGAAGCAGAGTGG
ATGTCCACTGTCACCAAGCTGGATGGCAAGCTGCGGCCCACAAAACAGCCAGTCAGGTTGGCTTTCCTGGTTTCAGACATGCTCATACCATTCCCATTTTCTCAGCCTCTTCTCACTGCCTCCAGAGA
GGTGGGTGCCTGGGTTGAGAGACACAGCTGCTACGTGATAGATGTTGAGAGACAGAAGCCAACGAAGGAGGTCATTCATCAACAAATATATTTATTGGAGACCGACTTTGTGCAAAGCAATGCTAATC
AGGGTTCTCCATGGAGCTTCCCTCAGCTCTTACCTCACCTCCCTCCATTTACATTAGGGCCTTCTCCCAGGGTGTGCTCGGTGGGCAGTGTGGGACTGGGGGTGTGGGAGTTGGTGAGAGCAGGAGGA
GAGGTGGGGACAGCAAGAAGCCACAGATTGGCATGAAGGATCCTGACCTGACTATCCATGCCATCCATGGCCCCCAGACTGACTCTGCACCTGGCCCTTTGCCAGACAGCTCTGTCTCCCCATGTCCT
CTGGAACAGCTGGGCATGGGTCATGGCCATTCATGACCCTTAAGTGCCACCCTTCTTGGAAGACCCCCTCCAGAAGCATACTGGAAGCCACCTCTGGAAAAGCCTCATATGGTGATATGCCAAAATAT
TTATGTCAATGTCCAAACAAAGTCCAATGCCATGAGACTGAAGTCTTTGTGGAAACCACTGTTACAGACAAGCTTATTTCCAAAGCCACCTCATTTCCAAACATCTCACTCAGGAAGGGAGGCTCAAT
GTAACCTCAGGGGCCAGTTTTAGCATTTGAAATGGTTCTGCTTGGAAAATGATGCCCTGCAACTAACCCTGGTCTTTCCCATGGCAATTTAACCACATTTGGAAGGCACTGCCTTCAGCTGAGTTTAT
GAACAATGAATGCCAACCTTCAGGTTCTAGAAGATTGGTTGCACTCCCAAACCTTTATTCTATTATATTACTATTAAAATATTCTAATTTTGCTATTGA

hide sequence


Protein RefSeqs	NP_005621	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAC09469	(Get FASTA)	NCBI Sequence Viewer
	AAH41140	(Get FASTA)	NCBI Sequence Viewer
	AAH51347	(Get FASTA)	NCBI Sequence Viewer
	BAE03223	(Get FASTA)	NCBI Sequence Viewer
	BAE03224	(Get FASTA)	NCBI Sequence Viewer
	BAE03225	(Get FASTA)	NCBI Sequence Viewer
	BAH13984	(Get FASTA)	NCBI Sequence Viewer
	EAW79156	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000311291
	ENSP00000311291.4
GenBank Protein	Q92959	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:

NP_005621 ⟸ NM_005630

- UniProtKB:

Q86V98 (UniProtKB/Swiss-Prot), Q8IUN2 (UniProtKB/Swiss-Prot), Q92959 (UniProtKB/Swiss-Prot), E7EU40 (UniProtKB/TrEMBL)

- Sequence:

show sequence

MGLLPKLGASQGSDTSTSRAGRCARSVFGNIKVFVLCQGLLQLCQLLYSAYFKSSLTTIEKRFGLSSSSSGLISSLNEISNAILIIFVSYFGSRVHRPRLIGIGGLFLAAGAFILTLPHFLSEPYQYT
LASTGNNSRLQAELCQKHWQDLPPSKCHSTTQNPQKETSSMWGLMVVAQLLAGIGTVPIQPFGISYVDDFSEPSNSPLYISILFAISVFGPAFGYLLGSVMLQIFVDYGRVNTAAVNLVPGDPRWIGA
WWLGLLISSALLVLTSFPFFFFPRAMPIGAKRAPATADEARKLEEAKSRGSLVDFIKRFPCIFLRLLMNSLFVLVVLAQCTFSSVIAGLSTFLNKFLEKQYGTSAAYANFLIGAVNLPAAALGMLFGG
ILMKRFVFSLQAIPRIATTIITISMILCVPLFFMGCSTPTVAEVYPPSTSSSIHPQSPACRRDCSCPDSIFHPVCGDNGIEYLSPCHAGCSNINMSSATSKQLIYLNCSCVTGGSASAKTGSCPVPCA
HFLLPAIFLISFVSLIACISHNPLYMMVLRVVNQEEKSFAIGVQFLLMRLLAWLPSPALYGLTIDHSCIRWNSLCLGRRGACAYYDNDALRDRYLGLQMGYKALGMLLLCFISWRVKKNKEYNVQKAA
GLI

hide sequence

Ensembl Acc Id:

ENSP00000418893 ⟸ ENST00000493729

Ensembl Acc Id:

ENSP00000420028 ⟸ ENST00000481359

Ensembl Acc Id:

ENSP00000311291 ⟸ ENST00000310926

Protein Domains

Kazal-like

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q92959-F1-model_v2	AlphaFold	Q92959	1-643	view protein structure

RGD ID:

6865740

Promoter ID:

EPDNEW_H6035

Type:

initiation region

Name:

SLCO2A1_1

Description:

solute carrier organic anion transporter family member 2A1

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H6036

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	134,029,925 - 134,029,985	EPDNEW

RGD ID:

6865742

Promoter ID:

EPDNEW_H6036

Type:

initiation region

Name:

SLCO2A1_2

Description:

solute carrier organic anion transporter family member 2A1

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H6035

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	134,030,062 - 134,030,122	EPDNEW

Database	Acc Id	Source(s)
COSMIC	SLCO2A1	COSMIC
Ensembl Genes	ENSG00000174640	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000310926	ENTREZGENE
	ENST00000310926.11	UniProtKB/Swiss-Prot
Gene3D-CATH	1.20.1250.20	UniProtKB/Swiss-Prot
	3.30.60.30	UniProtKB/Swiss-Prot
GTEx	ENSG00000174640	GTEx
HGNC ID	HGNC:10955	ENTREZGENE
Human Proteome Map	SLCO2A1	Human Proteome Map
InterPro	Kazal_dom	UniProtKB/Swiss-Prot
	Kazal_dom_sf	UniProtKB/Swiss-Prot
	MFS_dom	UniProtKB/Swiss-Prot
	MFS_trans_sf	UniProtKB/Swiss-Prot
	OATP	UniProtKB/Swiss-Prot
KEGG Report	hsa:6578	UniProtKB/Swiss-Prot
NCBI Gene	6578	ENTREZGENE
OMIM	601460	OMIM
PANTHER	PTHR11388	UniProtKB/Swiss-Prot
	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY MEMBER 2A1	UniProtKB/Swiss-Prot
Pfam	Kazal_2	UniProtKB/Swiss-Prot
	OATP	UniProtKB/Swiss-Prot
PharmGKB	PA35840	PharmGKB
PROSITE	KAZAL_2	UniProtKB/Swiss-Prot
	MFS	UniProtKB/Swiss-Prot
Superfamily-SCOP	SSF100895	UniProtKB/Swiss-Prot
	SSF103473	UniProtKB/Swiss-Prot
UniProt	E7EU40	ENTREZGENE, UniProtKB/TrEMBL
	F8W9W8_HUMAN	UniProtKB/TrEMBL
	Q86V98	ENTREZGENE
	Q8IUN2	ENTREZGENE
	Q92959	ENTREZGENE, UniProtKB/Swiss-Prot
UniProt Secondary	Q86V98	UniProtKB/Swiss-Prot
	Q8IUN2	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2016-03-29	SLCO2A1	solute carrier organic anion transporter family member 2A1	MATR1	matrin F/G 1	Data merged from RGD:1350110	737654	PROVISIONAL
2015-11-24	SLCO2A1	solute carrier organic anion transporter family member 2A1	SLCO2A1	solute carrier organic anion transporter family, member 2A1	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Imported Disease Annotations - ClinVar

Imported Disease Annotations - CTD

Imported Disease Annotations - OMIM

Imported Human Phenotype Annotations - HPO

Send us a Message

Imported Disease Annotations - ClinVar

Imported Disease Annotations - CTD

Imported Disease Annotations - OMIM

Imported Human Phenotype Annotations - HPO